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Abstract  
The need for the discovery of new pharmacologically active compounds is a global priority as 
new diseases and drug resistance mechanisms are emerging and spreading throughout the 
world. In the past natural products have played an important role in drug discovery. Plant-
derived natural products are important in the discovery of new drugs for treatment of infectious 
diseases and cancer.  
Many biologically active compounds with diverse structures have been isolated from the 
Euphorbiaceae family. In South Africa, Euphorbiaceae is the largest flowering plant family 
and some species within the family have not been investigated for unique secondary 
metabolites. However, many species have not been researched. This project aimed to identify 
bioactive compounds in South Africa Euphorbiaceae species. Two species within the 
Euphorbiaceae family, Euphorbia cooperi N.E.Br. ex A.Berger and Antidesma venosum 
E.Mey. ex Tul. were selected for investigation.  
The crude extracts were fractionated using column chromatography and centrifugal thin-layer 
chromatography to yield single compounds. A mixture of hexane, dichloromethane, 
chloroform, ethyl acetate and methanol were used as eluting solvents. The structures of the 
compounds isolated were elucidated by 1D and 2D NMR experiments (1H, 13C NMR, DEPT-
135, COSY, HSQC, HMBC and NOESY).  
The compounds isolated from A. venosum were identified as loliolide, β-sitosterol 3-O-β-D-
glucoside, lutein, 4-hydroxyphenylethyl trans-ferulate as well as pheophytin A and pheophytin 
B. Although these compounds are known compounds, only pheophytin A has previously been 
identified in A. venosum. 
A phytochemical study of the aerial part of E. cooperi has led to the isolation of a novel 
norsesquiterpenoid named euphorbilactone and its glucoside, arachiside A, along with a 
triterpenoid, glutinol, a known phorbol ester, 16-angeloyloxy-13α-isobutanoyloxy-4β,9α,20-
trihydroxytiglia-1,5-diene-3,7-dione, and a novel phorbol ester, 20-acetoxy-16-angeloyloxy-
13α-isobutanoyloxy-4β,9α,20-tetrahydroxytiglia-1,5-diene-3-one. This is the first report on the 
isolation of these compounds from E. cooperi. 
The crude extracts and loliolide, p-hydroxyphenylethyl trans-ferulate and β-sitosterol 3-O-β-
D-glucoside, were assayed for antimicrobial activities against one Gram-positive 
(Staphylococcus aureus ATCC 12600), two Gram-negative (Pseudomonas aeruginosa ATCC 
ii | P a g e  
 
10145, Klebsiella pneumoniae ATCC 13883), and one drug-resistant Gram-negative 
(Escherichia coli ATCC 25218) bacteria. The crude extracts of the plants showed moderate 
but promising antimicrobial activity. The pure compounds did not show any antimicrobial 
activity.  
This investigation has shown that South African Euphorbiaceae contains novel bioactive 
compounds. The two usual phorbol esters isolated from E cooperi warrant further investigation 
of the bioactivity of these compounds. 
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CHAPTER 1 
Introduction and Aims of the Project 
 
1.1 African traditional medicine 
The term traditional medicine1 and complementary alternative medicine2 are used 
interchangeably, depending on the cultural or ethnic groups interacting with traditional health 
practitioners. Complementary alternative medicine is mainly used in Western countries, 
whereas traditional medicine is mostly used in China and developing countries such as African 
countries.3 The World Health Organisation (WHO) defines traditional medicine as “Health 
practices, approaches, knowledge and beliefs incorporating plants, animals and mineral based 
medicine, spiritual therapies, manual techniques and exercises, applied singular or in 
combination, to treat, diagnose and prevent illnesses or maintain well-being”.4-5 The South 
African Traditional Health Practitioners Act 22 of 20076 describes traditional medicine as “An 
object or a substance that is used in traditional health practice for (i) the diagnosis, treatment 
or prevention of a physical or mental illness and (ii) any curative or therapeutic purpose, 
including the maintenance or restoration of physical or mental health or well-being in human 
beings but does not include a dependence-producing or dangerous substance or drug”.  
Traditional medicine systems across the world are dynamic and variable because of different 
regions and countries of origins and the various agricultural systems in which they exist.5 The 
“Primary Health Care Declaration of Alma-Ata” identified primary health care as an important 
part of “Health for All” and, for the first time, traditional medicine was included as part of 
primary health care. Traditional medicine was subsequently recognised by the “Traditional 
Medicine Programme” of the WHO.6-7  
In African countries, many people are treated with plant remedies by traditional healers. It is 
reported that in South Africa between 60% and 80% of the people consult traditional 
practitioners for primary health care.8-10 The reasons may be because some Western drugs are 
too expensive for many people to afford and in some areas, people must travel long distances 
to reach the nearest health facilities. The African continent has a vast variation in climate, plant 
species and cultures and has the human and natural resources to become leaders in the 
production of natural plant product and medicines.7 
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1.2 Natural products and drug discovery 
The use of natural products for medicinal purposes dates back practically to the start of human 
civilisation. Despite the advent of high-throughput synthesis and screening, and the post-
genomic era, natural products will remain an important source of future drugs.11-15  
Before the 20th century, the medications used to treat human illnesses were based on semi-pure 
and crude extracts from plants, animals, microbes and minerals. In the 20th century, it was 
discovered that chemical compounds in extracts were the main factors responsible for 
biological activity. This led to the hypothesis that the effect of a drug in the human body is 
mediated by a specific interaction of the molecule with biological macromolecules (proteins 
and nucleic acids).14 
The unique chemical structures of natural products have inspired medicinal chemists to use 
them as scaffolds for the design of drugs and chemical probes.15 Natural products have been 
successfully employed in the discovery of new drugs and have exerted a significant impact in 
chemico-biology (the chemistry of metabolic processes). The efficacy of natural products is 
related to the complexity of the unique three-dimensional structures as well as steric properties, 
which offer many benefits in terms of efficiency and selectivity of molecular targets.16 
Plants have been an important source of novel bioactive compounds with a diversity of 
pharmacologically active drugs being derived directly or indirectly from them. Despite the 
current progress by synthetic chemistry towards the discovery and manufacturing of drugs, the 
contribution of plants to disease treatment and prevention is still substantial. The 
pharmacological, clinical, and chemical studies of traditional medicines, which were 
predominantly derived from plants, led to the development of medications such as the 
painkiller drugs aspirin and morphine, the antimalarial drugs quinine and artemisinin, the 
glaucoma drug pilocarpine, the cardiac glycoside digitoxin, the anti-inflammatory, analgesic 
and antipyretic drug salicin, and the anticancer drug taxol. Natural products from 
microorganisms led to drugs such as the hypolipidemic agent mevastatin (Figure 1.1).14,17-23 
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Figure 1.1. Chemical structures of natural products used for medication.  
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1.3 Problem statement  
Antimicrobial resistance occurs when a microorganism (virus, bacteria and some parasites) 
mutate when exposed to antimicrobial drugs. This way the medication becomes inactive and 
infections persist in the body. Antimicrobial resistance is a global concern as new resistance 
mechanisms are emerging and spreading globally, threatening the current treatment and thus 
resulting in prolonged illnesses of influenza, HIV, malaria and tuberculosis (TB), which 
eventually causes death. In South Africa, TB continues to be the leading cause of death. About 
25 000 deaths caused by TB were recorded in 2015 by the WHO, and these excluded those 
people who had both HIV and TB infections when they died, as they were considered to have 
been killed by HIV.24-25 This urges the discovery of new antimicrobial agents. 
The human immunodeficiency virus (HIV) is a retrovirus that attacks human immune cells 
called CD4+ T cells and causes HIV infections and over time acquired immunodeficiency 
syndrome (AIDS). HIV/AIDS has killed 1 million people in 2016 worldwide.26 South Africa 
has the biggest HIV epidemic in the world, with about 7.1 million people living with HIV and 
a prevalence rate of approximately 18.9% among the general population.27 Accordingly, many 
efforts have been made to develop anti-HIV drugs. Although some drugs have been used 
successfully in the treatment of HIV infections, such as antiretroviral therapy,28 there are still 
problems with side effects and drug resistance. Furthermore, the current drugs can keep the 
viral load of a patient low but cannot eradicate the virus completely. Therefore, new and more 
potent anti-HIV agents are still needed. 
Cancer is an abnormal multiplication of cells in an uncontrolled manner. South Africa is ranked 
50th on the World Cancer Research Fund’s list of countries with the highest cancer prevalence 
rates. More than a 100 000 patients in  South Africa are diagnosed with cancer each year, and 
recent studies predict that South Africa could see an increase in the number of cancer cases by 
78% in 2030.29 Treatments for cancer include chemotherapy, radiotherapy and surgery. 
However, the prevention of tumour recurrence and the spread of cancer cells is difficult to 
achieve using these methods. Furthermore, tumour resistance to chemotherapeutic drugs is a 
serious problem and requires the discovery of novel adjuvant therapies. 
With the goal of discovering new lead compounds that can be developed into new bioactive 
drugs that can be used for the treatment of life-threatening diseases, we investigated some plant 
species within the Euphorbiaceae family, indigenous to South Africa. This plant family is 
known to contain diterpenes, amongst other bioactive compounds, as the major metabolites 
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with different unique structures of which some display a range of biological activities including 
anti-inflammatory, cytotoxic, antimicrobial, anti-HIV, and modulation of multidrug-resistance 
activities. Two plants species within this family were selected based on the mentioned 
phytochemical studies and the ethnopharmacological studies mentioned in the literature 
review, namely, Antidesma venosum E.Mey. ex Tul and Euphorbia cooperi N.E.Br. ex 
A.Berger. 
The research questions that I would like to address are: 
 Which bioactive compounds are present in South African Euphorbiaceae species? 
 What are the structures of these compounds? 
 How much of these compounds can be extracted or isolated from a given mass of plant 
material? 
 Can these compounds be used for the treatment for HIV, cancer and other diseases? 
1.4 Aims and objectives 
This project aimed to isolate bioactive compounds from indigenous Euphorbiaceae species and 
to investigate the structures and biological activities of these compounds. 
The objectives of this project were 
 To briefly review Euphorbiaceae species and diterpenoids present in this family 
 Identify species that have not been extensively investigated and of which plant material 
are readily available 
 Isolate compounds from the plant extracts and elucidate the structures 
 Investigate antibacterial activities of the crude extracts.  
 
In this theses, a literature review on the Euphorbiaceae family and diterpenoids is given in 
Chapter 2. Chapters 3 and 4 discuss the isolation and characterisation of compounds from A. 
venosum and E. cooperi, respectively. The overall conclusion and future work is presented in 
Chapter 5.   
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CHAPTER 2 
A Literature Review on the Euphorbiaceae and Diterpenoids 
 
2.1 Euphorbiaceae (Spurge family)  
Euphorbiaceae (Spurges) is the sixth largest flowering plant family consisting of more than 300 
genera and about 7 500 species, Orchidaceae being the largest flowering plant with more than 
19 000 species.30-32 This family has been admired for its life (growth) forms, including a variety 
of xerophytic species. Despite the great diversity of plants within the family, the plant members 
are united morphologically by the possession of a cyathium, a highly reduced inflorescence 
that resembles a single flower.33   
Spurges are an extraordinarily diverse group of dioecious or monoecious herbs, shrubs, 
geophytes, understory and canopy trees, vines, sometimes succulent or trees as well as an array 
of succulent and xerophytic forms. The leaves are generally alternate. The flowers are unisexual 
with 0-5 petals and 2-6 sepals; usually three carpels (tricarpellate ovary), three styles 
(sometimes divided), one ovule per locule, inflorescences often highly modified, fruits are 
schizocarp and seeds are usually arillate.32,34  
This family is known to have a wide range of beautiful and useful succulent plant species, 
including lawn weeds, cactus-like plant and poinsettias (Euphorbia pulcherrima); ornamental 
trees such as Codiaeum, sandbox tree (Hula crepitans and H. polyandra), copperleaf (Acalypha 
hispida), Phyllanthus, redbird cactus (Pedilanthus tithymaloides) and Jatropha. Some of the 
plant members of the family are of economic importance, such as castor-oil plant (Ricinus 
communis), croton (Croton tiglium), Omphalea, cassava (Manihot esculenta), rubber (Hevea 
brasiliensis), tung tree (Aleurites fordii) and tallow tree (Sapium sebiferum) (Figure 2.1.).35  
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Figure 2.1. Some plant species of the Euphorbiaceae family.  
 
 
https://www.rhs.org.uk/Plants/88057/Euphorbia-pulcherrima/Details 
Euphorbia pulcherrima 
 
 
 
https://en.wikipedia.org/wiki/Acalypha_hispida 
Acalypha hispida 
 
 
 
http://www.llifle.com/Encyclopedia/SUCCULENTS/Family/Euphorbiaceae/24098/Pedilanth
us_tithymaloides 
Pedilanthus tithymaloides 
 
 
https://www.helios.co.uk/shop/croton-tiglium 
Croton tiglium 
 
 
https://www.ebay.co.uk/itm/Tapioca-Tree-Cassava-Manihot-dulcis-12-Fresh-Seeds-
/380743890184 
Manihot esculenta 
 
 
http://www.horizon-custom-homes.com/HeveaBrasiliensis.html 
Hevea brasiliensis 
 
 
https://plants.ces.ncsu.edu/plants/all/aleurites-fordii/ 
Aleurites fordii 
 
https://www.ebay.com/itm/SAPIUM-Sebiferum-Chinese-Tallow-Tree-Seeds-ES-33-
/221989637711 
Sapium sebiferum 
 
http://www.ethnopharmacologia.org/recherche-dans-prelude/?plant_id=4560 
Phyllanthus niruri 
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Despite the vegetative variation, the plant family is united by a distinctive morphological 
synapomorphy, the cyathium, a pseudanthial inflorescence that looks typically like a dicot 
flower. This structural form is an intermediate between a flower and an inflorescence in 
development terms.33  
One of the significant characteristics of spurges is the sticky, irritant, milky sap called latex and 
common names are milky mangrove, buta-buta, and gewa (Figure 2.2).36-37 It is poisonous in 
the sub-family Euphorbioideae, and innocuous in the sub-family Crotonoideae.33 This type of 
fluid is found in trees, shrubs, lianas, both xerophytic succulents and water plants, it is more 
typically contained in tubes and cells which are collectively known as laticifer.36 The plants 
containing this latex use it as a defence mechanism for repelling browsing animals and insects, 
as well as killing and controlling the growth of microbial phytopathogens, and sealing wounded 
areas. It also contains low molecular weight rubber.38 For many plants like E. tirucalli and E. 
cooperi the latex is poisonous and possesses irritant properties toward the skin and mucous 
membranes. An example of a latex that is used medicinally is Euphorbium. Euphorbium is the 
air-dried latex of E. resinifera Berg. and is an over-the-counter drug used to suppress chronic 
pain, treat dental cavities to mitigate toothache, and treat tuberculosis, amongst others.37 
Euphorbiaceae latex contains a wide variety of classes of compounds including flavonoids, 
phenolic acids,39-40 tannins,41 diterpenoids, and triterpenoids, with diterpenoids being the 
dominant class of compounds.42 It has been shown that the highly unsaturated irritant phorbol 
esters are the main constituents responsible for the cytotoxicity of the latex.42 
 
Figure 2.2. Sticky, irritant, milky sap latex. 
 
The diterpenoids found in the Euphorbiaceae (also in the Thymelaeaceae) can be divided into 
six classes (based on the core framework), which are the tiglianes, ingenanes, daphnanes, 
lathyranes, jatrophanes, and abietanes (Figure 2.3).43  
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Figure 2.3. The core framework of diterpenoids from Euphorbiaceae.  
These classes of diterpenoids display a wide variety of biological activities, including anti-HIV, 
tumour-promoting, skin irritant, cytotoxic, and proinflammatory activities. The tiglianes are 
the compounds with the most exciting and diverse biological activities.44-46 
2.2 Tigliane diterpenes isolated from Euphorbiaceae plant species 
The core structure of the tigliane diterpenoids isolated from Euphorbiaceae has a tetracyclic 
ring system consisting of a five-membered ring A, a seven-membered ring B, a six-membered 
ring C and a cyclopropane ring D. The skeleton system contains twenty carbons which consist 
of five methyls, five methylenes, nine methines and one quaternary carbon (Figure 2.4). 
Generally, compounds belonging to this structural class of compounds contain two double 
bonds, one in ring B and another one in ring A. Ring A also contains an α,β-unsaturated 
ketone.47 
 
Figure 2.4. The skeletal structure of tigliane. 
A common tigliane diterpenoid, phorbol (1), was initially isolated from Croton tiglium.48 There 
are many tigliane diterpenoids derivatives derived from phorbol, including 4-deoxyphorbol, 
4,12-dideoxyphorbol, 4,20-dideoxyphorbol, 4,12,20-trideoxyphorbol, and 12-deoxyphorbol. 
The derivatives generally have hydroxy groups at C-12, C-13, C-16, and C-20, which can be 
readily esterified during biosynthesis. Tigliane derivatives derived from phorbol occur 
naturally as 13-monoesters, 12,13-, 13,16-, or 12,20-diesters, and 12,13,20- or 13,16,20-
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triesters, which have been esterified with acetic acid, isobutyric acid, tiglic acid, 2-
methylbutyric acid, benzoic acid, 2-methylaminobenzoic acid or saturated and unsaturated 
long-chain aliphatic fatty acids.47  
 
Phorbol (1) 
Some of the reported tigliane diterpenoids exist as aglycons. Only three tigliane glycosides, 2, 
3 and 4, have been isolated so far from plant species belonging to the Euphorbiaceae and 
Thymelaeaceae families.49 
  
Tigliane diterpenoids possess a wide variety of biological activities including anti-HIV, 
anticancer, tumour-promoting and pro-inflammatory activities.47 It has been reported that the 
active principles responsible for the irritancy of skin and mucous membranes caused by plant 
members of the Euphorbiaceae family are tigliane diterpenoids. Unlike other tigliane 
diterpenoids, phorbol (1) did not have irritant properties when tested in the mouse ear assay.50 
In this study, the measures of irritancy towards the skin of a mouse ear were in irritant dose 50 
(ID50) units. Phorbol 12-tetradecanoate 13-acetate (TPA) (5) displayed the highest irritant 
activity of (ID50 = 0.016 nmol/ear) in this assay. The ID50 results of other related phorbol 
derivatives showed that an increase in the number of carbon atoms or an increase in the number 
of double bonds in a fixed number of carbon atoms in the acyl moiety leads to an increase in 
irritant activity of the investigated compounds.50 
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Phorbol 12-tetradecanoate 13-acetate (TPA) (5) 
There is a significant interest in tigliane diterpenes because of their tumourigenic and 
cocarcinogen activities. Some of the naturally occurring diterpenoids cocarcinogens are potent 
skin blistering and reddening agents. Some are classified as tumour promoters, but that does 
not imply that these are also cocarcinogens. Only after the initiating agents have initiated 
carcinogenesis can the tumour promoters function, whereas cocarcinogens enhance tumour 
yield when applied together with carcinogens.51 TPA was reported not to be a carcinogen, but 
a cocarcinogen that was classified as a tumour promoter. It has been reported that of all the 13-
monoester derivatives of 12-deoxyphorbol tested so far, only 12-deoxyphorbol 13-
tetradecanoate (6) has shown a level of cocarcinogenic activity similar to that of TPA. In 
contrast to TPA, 12-deoxyphorbol esters possess intermediate hydrophobicity with tigliate, 
isobutyrate, and phenylacetate esters and these are regarded as inflammation agents but only 
weakly tumour promoting or nonpromoting. Esters of 12-deoxy-16-hydroxy-phorbol have 
been shown to be weaker tumour promoters than TPA.52 
 
12-Deoxyphorbol 13-tetradecanoate (6) 
Although tigliane diterpenoids exhibit tumour-promoting activities, studies have revealed that 
some derivatives show significant anticancer activity. 12-Deoxyphorbol derivatives 7-9, 
isolated from Baliospermum montanum, exhibited antileukaemic activity with ED50 values 
ranging from 0.4 to 3.4 μg/mL in a P-388 lymphocytic leukaemia system in vitro.53  
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Figure 2.5. 12-Deoxyphorbol derivatives with antileukaemic activity. 
The 12-deoxyphorbol esters 10-12, isolated from Euphobia fischeriana, showed potent 
cytotoxic activity against Ramos B-cells. The activity was enhanced by the presence of the 
long acyl chain at C-13 and a free hydroxyl group at C-20 when compared to the other 
compounds tested on the same cells. These phorbol esters also exhibited non-tumour-
promoting activity.54-55 
 
Figure 2.6. 12-Deoxyphorbol esters with potent cytotoxic activity against Ramos B cells.  
Tigliane diterpenoids possess remarkable anti-HIV activity. Current HIV medication leads to 
a substantial reduction of actively replicating viruses but cannot eradicate reservoirs with latent 
HIV and patients need to use these drugs on a continuing basis.  Prostratin (13) is a protein 
kinase C (PKC) activator isolated from the bark of mamala tree of Samoa, Homalanthus nutans 
(Euphorbiaceae). Prostratin is a preclinical candidate that has the potential to eliminate latently 
infected CD4+ T cells through a virus-induced cytopathic effect or host anti-HIV immunity.  
Derivatives of 13 are more potent than the preclinical lead (prostratin) in binding to cell-free 
PKC and inducing HIV expression in latently infected cells; 2-deoxyphorbol 13-
phenylacetate (14) is one of them. Recent studies have shown that this compound is ten-fold 
more potent than 13 in the PKC binding assays, 20-40 times more potent at inducing viral 
production in latently infected cells and at least five times more potent at inducing viral 
expression from human peripheral blood mononuclear cells.17,43,47,56-58  
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Figure 2.7. The chemical structures of prostratin (13) and 12-deoxyphorbol 13-phenylacetate 
(14).  
Other classes of diterpenoids possess some interesting biological activities. Ingenol mebutate 
(ingenol 3-angelate) (15), an ester of the diterpene ingenol and angelic acid, was extracted from 
the latex of E. peplus.59 Several controlled studies have shown that 15 can be used in the 
treatment of basal cell carcinoma, non-melanoma skin cancer, and actinic keratoses and for the 
reactivation of latent HIV  at a nanomolar level in primary CD4+ T cells from HIV infected 
individuals receiving ART.59-60 Ingenol mebutate (15) has been approved by the United States 
Food and Drug Administration (FDA) and the European Medicines Agency for the topical 
treatment of actinic keratosis. 
 
 
Figure 2.8. Chemical structure of ingenol mebutate (15) and 3-O-caproyl-ingenol (16). 
Another semi-synthetic ingenol ester is 3-O-caproylingenol (16), which is more potent in 
reactivating latent HIV than known activators such as ingenol 3,20-dibenzoate (17), 
hexamethylene bisacetamide (18) and suberoylanilide hydroxamic acid (19).61 
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A bioactive compound, euphol (20), which was extracted from E. tirucalli latex, is an euphane-
type triterpene alcohol with anti-inflammatory activities on human gastric cancer cells. It 
exhibits cytotoxic effects against a number of cancer cell lines, with most prominent effects 
against oesophageal squamous cells, pancreatic cell carcinomas, and human gastric cancer. The 
literature reveals that a topical application of euphol suppresses tumour-promoting effect in 2-
stage carcinogenesis in mouse skin. However, the mechanisms explaining this effect as well as 
the antitumour properties of euphol remain to be evaluated.62-65  
 
Euphol (20) 
Recently, a novel tetracyclic triterpenoid with an unusual spiro scaffold, spiropedroxodiol (21), 
was isolated from Euphorbia pedroi. The compound displayed strong multidrug-resistance 
reversal activity in both L5178Y-MDR and human colo320 cells. In combination assays, 
compound 21 enhanced synergistically the cytotoxicity of doxorubicin (22), which was the 
positive control in the assay.66 
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It is clear that the plant members of the Euphorbiaceae have the potential of producing 
interesting biologically active compounds. The family contain diterpenoids as the major 
metabolites and the activities of these compounds include anti-HIV, anti-cancer and 
antimicrobial activity. The Euphorbiaceae are well presented in South Africa, with at least 188 
Euphorbia species recorded as indigenous to the country. Furthermore, there are other genera 
in the family, such as Antidesma, Acalypha and Croton, amongst others, that are indigenous to 
South Africa. The phytochemistry of many Euphorbiaceae has not been recorded. Furthermore, 
the biological activities of many of the diterpenoids that have been isolated, are not known.  
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CHAPTER 3 
Phytochemistry of Antidesma venosum E.Mey. ex Tul. 
 
3.1 Introduction 
3.1.1 Antidesma Genus 
Antidesma L. is a genus that belongs to the subtribe Antidesminae in the subfamily 
Phyllanthoideae within the Euphorbiaceae family, and the plants are often found in the 
understorey of tropical rain forests or shrubby vegetation. Its distribution ranges from West 
Africa to the Pacific Islands and from the Himalayas to Northern Australia with the centre of 
diversity in Southeast Asia (Malaysian region). The genus comprises approximately 110 
species worldwide.67 
The species of the genus are either short and shrubby or tall and erect and can be up to 30 
metres in height. The large, oval-shaped, leathery and evergreen (sometimes deciduous) leaves 
are up to 20 centimetres long and 7 centimetres wide with fine hairs underneath. The leaves 
grow in an alternate arrangement, with entire, symmetrical blades connected to the stem with 
petioles and stipules. Flowers of this genus have a strong and unpleasant scent, and the colours 
are light yellow-greenish, which may turn red when mature. This species is unisexual, with 
male and female flowers on separate plants. The staminate flowers are arranged in small 
bunches, and the pistillate flowers grow on long racemes with a single bract per flower on a 
short pedicel which becomes the strands of fruits. The spherical fruits are less than one 
centimetre wide, hanging singly or paired in long, heavy bunches. The fruits are white when 
immature and gradually turn red and then black when fully matured.68-69  
3.1.2 Bioactive compounds from Antidesma  
Plant species belonging to this genus contain a variety of bioactive compounds including 
phenolic compounds, coumarins, tannins, and alkaloids, amongst others, of which some 
displayed antioxidant, antimicrobial and cytotoxic activities.70-72 
Acidumonate (23), isolated from Antidesma acidum Retz., is a monophenolic compound 
comprising of two ketone groups, two methoxy groups and one methyl ester moiety. It was 
reported that this compound displays promising cytotoxicity against both Hb and HeLa cancer 
cells with IC50 values of 2.60 and 3.80 µg/mL, respectively.
73 
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Acidumonate (23) 
Antidesmanin A (24), antidesmanin B (25) and antidesmanin C (26) are coumarinolignans that 
were isolated from Antidesma pentandrum var. barbatum (C.Presl) Merr. These compounds 
showed marginal cytotoxicity against MCF-7 (breast) and SF-268(CNS) cancer cells in vitro.74 
 
 
 
Antidesmone (27) is a unique tetrahydroquinoline alkaloid that was isolated from Antidesma 
membranaceum Müll.Arg.75 This alkaloid was also found in the stems of Waltheria douradinha 
A.St.-Hil.76 and Waltheria indica L.77 (Malvaceae) and is used for the treatment of respiratory 
disorders, urinary problems and wounds. Antidesmone is also present in the roots of Melochia 
chamaedrys (Sterculiaceae), which is commonly used in South Africa as a herbal medicine.78 
 
Antidesmone (27) 
Two alkaloids, clauszoline B (28) and 7-methoxymukonal (29), were recently isolated from 
the leaves of A. acidum. These compounds are significantly cytotoxic towards HL-60 cancer 
cells with IC50 values of 4.8±0.2 and 8.0±0.9 μM, respectively, but the compounds did not 
inhibit the growth of HEL-99, a normal cell line. Compound 28 induced apoptosis via alteration 
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of expression of apoptosis-related proteins and decreased phosphorylation of AKT in HL-60 
cells.79 
 
 
3.1.3 Antidesma venosum E.Mey. ex Tul. 
Antidesma venosum E.Mey. ex Tul. (Euphorbiaceae) (Figure 3.1) is known as isiBangamlotha 
(isiZulu), tassel-berry (English), voëlsitboom (Afrikaans).44 A. venosum is an evergreen tree 
that can grow up to 15 m in height. The oval to elliptical leathery leaves, up to 150 mm long 
and 70 mm broad, are bright glossy green above and hairy below. The reddish flowers have an 
unpleasant smell and attract insects and insect-eating birds. Fruits are tiny, almost oval, about 
8-10 mm in diameter, whitish when young but turn green to red and finally black when 
matured.70,80 This plant species occurs in coastal areas of some tropical countries with sandy 
soils. In South Africa, the plant is found in Eastern Cape, KwaZulu-Natal, Mpumalanga and 
Limpopo.80 
 
Figure 3.1. Antidesma venosum E.Mey. ex Tul.  
A. venosum is used for decorative purposes in large gardens and bird parks. The wood of the 
tree is used for building huts, for firewood, knife sheaths and tool handles. The leaves and roots 
are used for treating snakebites, abnormal pain, hookworm and heart diseases.70     
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The literature reveals only one report on the phytochemistry of the plant81 and five reports on 
the biological screening of the plant extract.71-72,82-84 According to the phytochemical report,81 
eight compounds, friedelin (30), epifriedelanol (31), betulinic acid (32), toddaculin (33), α-
tocopherol (34), pheophytin A, presqualene alcohol (35), and its acetate derivative (36), were 
isolated from the root bark of the plant. Qualitative phytochemical screening of A. venosum 
revealed the presence of four classes of compounds namely, alkaloids, flavonoids, saponins 
and tannins from the stem bark of the plant. The stem bark extract of the plant showed strong 
antimicrobial activity.71 
 
 3.2 Results and discussion 
Based on the literature reports on the plant,71-72,81-84 only the roots were previously investigated 
for secondary metabolites. The leaves and the stems were only assayed for biological activity, 
and based on that it was decided that both the leaves and stems should be further investigated 
secondary metabolite. The leaves of A. venosum should be extracted separately with DCM and 
MeOH. The leaves were extracted with DCM. MeOH extraction of the leaves was omitted due 
to time constraints. The stems were extracted with a DCM-MeOH mixture (1:1, v/v). The crude 
extracts were subjected to column chromatography using a mixture of Hex and EtOAc for the 
leaves and DCM with MeOH for the stems as eluents. Further purification of the fractions 
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obtained from column chromatography and centrifugal thin-layer chromatography afforded 
compounds 37 - 40 from the leaf extract, and 41 and 42 from the branch extract. The structures 
were elucidated using 1H NMR, 13C NMR, DEPT-135, COSY, HSQC, HMBC and TOF-MS.  
3.2.1 Structural elucidation of loliolide (37) 
 
37 
Compound 37 was isolated as a white powder. In the HR-ESI-(+)-MS spectrum (Figure 3.2) a 
sodium adduct of the molecular ion was observed at m/z 219.0992, corresponding to a molecular 
formula of C11H16O3 (calcd for C11H16O3Na, 219.0997). 
  
Figure 3.2. HR-ESI-(+)-MS spectrum of compound 37. 
The 1H NMR spectrum of compound 37 (Figure 3.3) showed the presence of a vinylic proton 
at δH 5.69 (H-3, s) and two pairs of diastereotopic methylene protons at δH 2.46 (1H, dt, J = 14.1 
and 2.7 Hz, H-5ax) and δH 1.72 (1H, dd, J = 13.4 and 4.1 Hz, H-5eq), as well as δH 1.98 (1H, dt, 
J = 14.4 and 2.5 Hz, H-7ax) and δH 1.53 (1H, dd, J = 14.5 Hz, 3.5 Hz,  H-7eq) (the latter resonance 
was partly obscured by a residual water resonance). Three methyl proton resonances were 
observed as singlets at δH 1.27 (H-9, s), 1.47 (H-10, s) and 1.78 (H-8, s). A residual resonance 
for DCM was observed at δH 5.30. 
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Figure 3.3. 1H NMR spectrum of compound 37 in CDCl3 (400 MHz). 
The 13C NMR and DEPT-135 spectra (Figure 3.4) showed twelve carbon signals. Three sp2 
carbon resonances were observed at δC 182.6, δC 172.1 and δC 113.2, corresponding to a carbonyl 
and two alkene carbons. A 13C chemical shift of δC 172.1 is in agreement with a lactone carbonyl. 
The other two resonances were assigned to an α,β-unsaturated carbonyl moiety. The chemical 
shift of the carbon signal resonating at δC 86.8 indicated a carbon bearing an electronegative 
atom, most likely oxygen. The last quaternary carbon resonating at δC 36.1 was assigned to a 
carbon bonded to alkyl groups. Two methylene carbons, resonating at δC 47.6 and δC 45.9 were 
observed as negative signals in the DEPT-135 spectrum. A methine carbon resonating at δC 67.1 
and three methyls at δC 30.9, δC 27.2 and δC 26.7 were observed in the spectrum. 
 
Figure 3.4. 13C NMR and DEPT-135 spectra of 37 in CDCl3 (100 MHz). 
The HSQC NMR spectrum (Figure 3.5) was useful in unravelling the C-H framework of 
compound 37. From the spectrum the assignment of three methyl groups (δH 1.27, 1.47 and 1.78; 
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δC 30.9, 26.2 and 27.2, respectively), two methylene groups (δH 2.46, 1.72 and δH 1.98, 1.53; δC 
45.9 and 47.6, respectively), one vinylic group (δH 5.69, δC 113.2) and one oxygen-bearing C-H 
group (δH 4.32, δC 67.1) was possible. The 1H-1H COSY NMR spectrum (Figure 3.6) showed 
the correlations of the diastereotopic methylene protons (δH 2.46 (Heq) and δH 1.72 (Hax), δH 1.98 
(Heq) and δH 1.53 (Hax)) with the proton at δH 4.32 (red). Each pair of diastereotopic protons 
showed a correlation with the geminal proton and, in addition, a W-coupling (4-bond coupling) 
was observed between the two equatorial protons (green). The chemical shift of the resonance at 
δH 4.32 indicated that the proton was attached to an oxygen-bearing carbon atom. The splitting 
pattern is a quintet with a coupling constant of J = 3.4 Hz, characteristic of an equatorial proton. 
The coupling constants and the differences in chemical shifts observed in the 1H NMR spectrum 
as well as the COSY correlations of the diastereotopic protons indicated that these protons were 
most likely part of a six-membered ring in a chair conformation (Figure 3.7). 
 
Figure 3.5. HSQC NMR spectra of compound 37. 
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Figure 3.6. COSY NMR spectrum of compound 37 
.  
Figure 3.7. Observed COSY correlations for compound 37. 
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Figure 3.8 HMBC NMR spectrum of 37. 
A 1H-13C HMBC NMR spectrum (Figure 3.8) was useful in assembling the final pieces of the 
structure of compound 37. 2J and 3J C-H couplings were observed in this spectrum. Correlations 
between H-3 and the four quaternary carbons, δC 182.6, 172.1, 86.8, and 36.1 (assigned to C-3a, 
C-2, C-7a and C-4, respectively) were observed (blue circles). The proton resonating at δH 4.32 
(H-6) (δC 67.1, C-6) showed correlations to two quaternary carbons (δC 36.1 and δC 86.8, C-4 and 
C-7a, respectively) (orange circles). Correlations between the two pairs diastereotopic protons 
(H-5 and H-7) and multiple carbons in the compound were observed (green and red circles). The 
1H-13C correlations of the two methyl resonances at δH 1.47 (δC 26.7) and δH 1.27 (δC 30.9) to 
the same quaternary carbon nuclei (δC 36.1) (purple circles) and to each other, confirmed the 
presence of a geminal dimethyl moiety. The structure was assigned as a six-membered ring 
attached to a five-membered lactone ring. Thus, 37 was identified as loliolide and the 
spectroscopic data were in agreement with the literature values.85-87 The NMR data are collated 
in Table 3.1 
Loliolide (37) is one of the degradation products of carotenoids and was first isolated from 
Fumaria officinalis in 193888 but the chemical structure was only elucidated in 1964 by Hodges 
and Porte89 and it was synthesised for the first time by Marx and Sondheimer in 1966.90 This 
compound is also present in marine organisms and algae. In marine algae, it is reported that 37 
is a photo-oxidation product of algal carotenoids and as such, it is used by phytoplankton in 
sediments as a biomarker for photo-oxidative alterations and is regarded as a phytotoxic 
compound with various effects such as inhibition of algal growth and germination,  as well an 
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ant-repelling activity.91 Recent studies have classified loliolide as a potent inhibitor of hepatitis 
C virus entry.92 Loliolide has showed an affinity to the serotonin transporter in a study to identify 
natural products with anti-depression activity.93  
Table 3.1. 1H (400 MHz) and 13C (100 MHz) NMR data of compound 37 in CDCl3. 
Position δH (ppm) (J in Hz) δC (ppm) δC (ppm) literature 
2 - 172.1 171.2 
3 5.69 (1H, s) 113.2 112.9 
3a - 182.6 182.8 
4 - 36.1 36.1 
5ax 1.54 (1H, dd, 13.4, 4.1) 47.6 47.2 
5eq 1.98 (1H, dt, 14.1, 2.7)   
6 4.32 (1H, q, 3.4) 67.1 66.7 
7ax 1.79 (1H, dd, 14.5, 3.5) 45.9 45.4 
7eq 2.46 (1H, dt, 14.4, 2.5)   
7a - 86.8 86.9 
8 1.78 (3H, s) 27.2 26.8 
9 1.27 (3H, s) 30.9 30.6 
10 1.47(3H, s) 26.7 26.5 
 
3.2.2 Structural elucidation of lutein (38) 
 
38 
Compound 38 was isolated as an orange, amorphous powder. In the HR-ESI-(-)-MS spectrum 
(Figure 3.9), a quasi-molecular ion [M-H]- was observed at m/z 567.4180, corresponding to a 
molecular formula of C40H56O2 (calcd for C40H55O2, 567.4202).
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Figure 3.9. HR-ESI-(-)-MS spectrum of compound 38.  
The 1H NMR spectrum (Figure 3.10) revealed the presence of a long conjugated chain of 
vinylic protons resembling a carotenoid-type compound with resonances downfield between 
δH 6.12-6.67. Two signals resonating at δH 4.01 and δH 4.25 were assigned to protons bonded 
to two oxygen-bearing carbons. Eight methyl singlets were observed upfield, two of them 
having similar intensities and each integrated for six protons, which gave a total of ten methyl 
groups. 
 
Figure 3.10. 1H NMR spectrum of compound 38 in CDCl3 (400 MHz). 
The 13C NMR and DEPT-135 spectra (Figure 3.11) showed 40 carbon resonances, which 
were identified by the DEPT-135 and HSQC spectra (Figure 3.12) as nine quaternary carbons, 
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two methines (oxygen-bearing carbons), fifteen olefinic carbons, two methylene carbons and 
ten methyls.  
 
Figure 3.11. 13C and DEPT-135 NMR spectra of compound 38 (100 MHz).  
 
Figure 3.12. HSQC NMR spectrum of compound 38. 
The 1H-1H COSY (Figure 3.13) NMR spectrum showed the correlations between protons 
resonating at δH 5.43 and δH 2.43 as well as δH 6.16, δH 6.64 - 6.68 and both 6.38, δH 6.12, δH 
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5.55 and both δH 4.25 and δH 1.63. These correlations confirmed the presence of an extended 
conjugated chain. 1H-1H coupling was observed between the geminal protons Heq and Hax (δH 
1.88 and δH 1.37) and δH 4.25, confirming the presence of a hydroxylated six-membered ring. 
A similar correlation was observed between the proton resonating at δH 4.01 and a pair of 
methylene protons, Hax′ and Heq′ (δH 1.48 and δH 1.77) and also with two methylene protons 
resonating at δH 1.26, thus confirming the presence of a second six-membered ring (Figure 
3.14). 
 
Figure 3.13. COSY NMR spectrum of compound 38 
.  
Figure 3.14. Correlations observed in the 1H-1H COSY NMR spectrum for compound 38. 
The long-range 1H-13C correlations observed in the HMBC NMR spectrum (Figure 3.15) was 
useful in the determination of the structure. Correlations between the methyl protons 
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resonating at δH 0.85 and δH 1.00 and a tertiary carbon resonance at δC 55.0, a quaternary 
carbon resonance at δC 33.9 and a secondary carbon resonance at δC 44.5 (C-2) further 
confirmed the presence of a six-membered ring with 1 degree of unsaturation (Figure 3.16). 
The second ring which was confirmed by the correlation between the overlapping methyl 
protons resonating at δH 1.08 (δC 28.6 and δC 30.1), and two secondary carbons (δC 48.3 and 
δC 29.6) and one quaternary carbon (δC 37.1). The difference between the two rings was the 
position of the double bond. The HMBC correlation of the olefinic protons and methyls in the 
conjugated chain confirmed the presence of a carotenoid-like conjugated chain. Thus 
compound 38 was identified as lutein and the spectroscopic data were in agreement with the 
literature values.94-95 The NMR data are collated in Table 3.2 
 
Figure 3.15 HMBC NMR spectrum of compound 38. 
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Figure 3.16. Long-range 1H-13C HMBC correlations observed for compound 38. 
Lutein is a naturally occurring carotenoid that is classified as a xanthophyll and is synthesised 
only by higher plants. The plant uses it as a modulator of light energy and as a non-
photochemical quenching agent to reduce the overproduction of triple chlorophyll during 
photosynthesis.96 In humans, lutein, together with zeaxanthin, accumulates in the retina of the 
eye as well as in the brain.97 These carotenoids play an essential role in human vision by 
preventing hypoxia-induced cell damage in the eye, by reducing the amount of the blue light 
that reaches the photoreceptors, preventing age-related macular degeneration, and has 
antioxidant and anti-inflammatory properties.98 Lutein induces the α-1,3-glucan accumulation 
on the cell wall surface of fungal plant pathogens.95 
Table 3.2. 1H (400 MHz) and 13C (100 MHz) NMR data of compound 38 in CDCl3.  
Position         δH (ppm) (J in Hz) δC (ppm) δC (ppm) literature 
1 - 33.9 34.0 
2ax   1.37 (1H, d, 2) 44.5 44.7 
2eq       1.84 (1H, dd, 4, 6)   
3 4.25 (1H, brs) 65.0 65.9 
4 5.55 (1H, brs)  124.4 124.9 
5 - 126.0 126.2 
6 2.43 (1H, brs) 55.0 55.0 
7 5.43 (1H, dd, 10, 6) 128.6 128.7 
8 6.16 (1H, d,5) 137.6 137.9 
9 - 134.9 135.7 
10 6.12 (1H, brs) 138.4 - 
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11 6.64-6.68 (1H, m) 129.9 129.9 
12 6.38 (1H, brs)  137.5 12.8 
13 - 135.5 137.6 
14 6.24-6.26 (1H, d, 10) 132.4 132.6 
15 6.57-6.62 (1H, m) 124.8 - 
16 0.85 (3H, s) 24.2 - 
17 1.00 (3H, s) 29.4 30.3 
18 1.63(3H, s) 22.7 22.9 
19 1.74 (3H, s)  21.5 20.7 
20 1.26 (3H, s) 22.7 - 
1′ - 37.0 37.1 
2′ 1.26 (2H, s) 29.6 - 
3′ 4.01 (1H, brs) 65.9 65.9 
4′ax 1.48 (1H, t, 12)  
48.3 
- 
4′eq 1.77 (1H, t, 4) - 
5′ - 126.0 126.3 
6′ - 137.8 137.6 
7′ 6.15*  130.7 - 
8′ 6.16 (1H, d, 5) 137.6 - 
9′ - 136.3 137.6 
10′ 6.12 (1H, brs) 125.5 - 
11′ 6.64-6.68 (1H m) 124.8 124.5 
12′ 6.33 (1H, d) 137.5 137.6 
13′ - 136.2 137.6 
14′ 6.24-6.26 (1H, m) 132.4 132.6 
15′ 6.57-6.62 (1H, m) 124.8 - 
16′ 1.08 (3H, s) 30.1 29.5 
17′ 1.08 (3H, s) 28.6 12.8 
18′ 0.88 (3H, s)  14.0 - 
19′ 1.91(3H, s) 12.7 12.11 
20′ 1.97 (3H, s) 13.0 12.8 
              * Undefined multiplicity due to overlapping 
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3.2.3 Structural elucidation of pheophytin A (39) and pheophytin B (40) 
 
Compound 39 was isolated as a dark solid. In the HR-ESI-(+)-MS spectrum (Figure 3.17), a 
sodium adduct was observed at m/z 893.5536, corresponding to a molecular formula of 
C55H74N4O5 (calcd for C55H74N4O5Na, 893.5557).
  
 
Figure 3.17. HR-ESI-(+)-MS for compound 39. 
Compound 40 was isolated as a brown solid. Three downfield singlet resonances on the 1H 
NMR spectrum of 39 (Figure 3.18), δH 9.39, δH 9.49 and δH 8.55 were observed, corresponding 
to three aromatic methines of a porphyrin at positions C-5, C-10 and C-20. Two doublet of 
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doublets signals resonating at δH 6.16 and δH 6.26, corresponding to the cis- and trans-olefinic 
protons at position C-3′′, and one doublet doublets resonating at δH 7.97 was assigned to H-3′. 
The NH signal appeared as a broad singlet resonating upfield at δH -1.59. Similar resonances 
in the 1H NMR spectrum (Figure 3.19) were observed for compound 40, except that there was 
an additional singlet downfield at δH 11.04 corresponding to an aldehyde at position C-7. 
Comparing the chemical shifts of the protons at position C-5 of compounds 39 and 40, a slight 
shift was observed which was due to the presence of an electron withdrawing carbonyl of the 
ketone moiety at position C-7 (shifting from δH 9.39 to δH 10.25). The carbon resonances at δC 
174.0 and δC 169.3 were assigned to the ester carbonyls C-17′′′ and C-13′′′, respectively, and a 
ketone carbonyl to the resonance at δC 189.5. The rest of the NMR data (Plate 1 – Plate 9 in the 
Addendum) were in agreement with the NMR resonances published for pheophytin A (39) and 
pheophytin B (40).99-101  
 
Figure 3.18. 1H NMR spectrum of compound 39 in CDCl3 (400 MHz). 
 
Figure 3.19. 1H NMR spectrum of compound 40 in CDCl3 (400 MHz). 
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Both pheophytin A and pheophytin B are porphyrin compounds formed by the degradation of 
a major photosynthesis pigment of plants and marine algae, chlorophyll, with magnesium as 
the central atom. In marine algae, pheophytin A enhances signal transduction in the mitogen-
activated protein kinase-signalling pathway and promotes the differentiation of PC12 cell.100 
A study of a bioactivity-guided screening of Lonicera hypoglauca Miq identified pheophytin 
A as a potent anti-hepatitis C virus agent.102 Pheophytin A also has antioxidant activities.103 No 
activity has been reported for pheophytin B.  
3.2.5 Structural elucidation of β-sitosterol 3-O-β-D-glucoside (41) 
 
Compound 41 was isolated as a white crystalline solid from the branch extract of A. venosum. 
In the HR-ESI-(-)-MS spectrum (Figure 3.20) a chlorine adduct [M+Cl]- was observed at m/z 
611.4071, corresponding to a molecular formula of C35H60O6 (calcd for C35H60O6Cl, 611.4078). 
 
Figure 3.20. HR-ESI-(-)-MS of compound 41.  
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The 1H NMR spectrum (Figure 3.21) showed the resonances of the protons for the glucose 
moiety at δH 3.18 (H-2’), 3.27 (H-5’), 3.36 (H-4’), 3.39 (H-3’), 3.84 (H-6’eq) and 3.71 (H-6’ax) 
and an anomeric proton resonating at δH 4.38 (d, J = 8 Hz). The chemical shift and coupling 
constant of the anomeric proton confirms the presence of an O-glycosidic bond and the β-
anomeric proton. The spectrum reveals the presence of a steroid-type substructure with six 
methyl groups resonating at δH 0.68 (s), 1.00 (s), 0.83 (d), 0.93 (d) and 0.81(t). H-6 appeared as 
a multiplet at δH 5.39. 
 
Figure 3.21. 1H NMR spectrum of compound 41 in CD3OD (400 MHz). 
The 13C and DEPT-135 NMR spectrum (Figure 3.22) showed the presence of 35 carbon 
resonances, which, based on the HSQC spectrum (Figure 3.23), were assigned as six carbon 
resonances of a glucose moiety, and a total of 29 carbon resonances of the steroid moiety.  
 
Figure 3.22. 13C and DEPT-135 NMR spectra of compound 41 (100 MHz). 
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Figure 3.23. HSQC NMR spectra of compound 41. 
In the 1H-1H COSY (Figure 3.24) NMR spectrum the anomeric proton resonating at δH 4.38 
(H-1’) correlated to another glucose proton at δH 3.18 (H-2’), which in turn correlated the 
proton resonance at δH 3.39 (H-3’) (purple circles). The methylene protons at δH 3.71 (H-6’ax) 
and 3.84 (H-6’eq) correlated to the proton resonance at δH 3.27 (H-5’) (orange circles). A 
correlation was observed between the olefinic proton δH 5.38 (H-6) and the methylene protons 
resonating at δH 1.85 (H-7) (Figure 3.25). 
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Figure 3.24. The COSY NMR spectrum of compound 41. 
 
 Figure 3.25 COSY correlations observed for compound 41. 
 
 
Figure 3.26 HMBC NMR spectrum of compound 41 
 
Figure 3.27. HMBC correlations observed for compound 41. 
The final confirmation of the structure of compound 41 was based on long-range 1H-13C 
HMBC correlations observed in the HMBC NMR spectrum (Figure 3.26). The presence of 
an O-glycosidic bridge between a glucose moiety and steroid was confirmed by a 3JCH HMBC 
correlation between an anomeric proton δH 4.38 (H-1’) and a carbon resonating at δC 77.6 (C-
3) (red circle). Two 2JCH correlations of the methyl protons at δH 1.00 (H-19) to δC 144.4 (C-
5) and δC 36.9 (C-10), as well as a 3JCH correlation to δC 51.2 (C-8),  were observed (purple 
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circles). It can be concluded from long-range 1H-13C HMBC correlation of the rest of the 
methyl protons of the sitosterol moiety (green circles) and comparison with reported NMR 
spectra that the steroidal moiety was β-sitosterol. Since there was an O-glycosidic bridge 
present and the HMBC correlation was observed between the anomeric proton and C-3 of the 
steroid it was could be concluded that compound 41 is β-sitosterol 3-O-β-D-glucoside. The 
spectroscopic data of 41 was in agreement with the literature values.104-105 The NMR data are 
collated in Table 3.3. 
β-Sitosterol 3-O-β-D-glucoside is a phytosterol glucoside that is a primer for cellulose 
synthesis.106 This compound was reported to have anti-inflammatory activity,107 and was also 
classified as a potent neurotoxic agent.108 β-Sitosterol 3-O-β-D-glucoside was also identified 
to stimulate human peripheral blood lymphocyte proliferation thus implying that it can be used 
as an immunomodulatory vitamin in combination with β-sitosterol.109 It also reported that this 
compound has anti-breast cancer activity.110 
Table 3.3. 1H (400 MHz) and 13C (100 MHz) NMR data of compound 41 in CDCl3. 
Position δH (ppm) (J in Hz) δC (ppm) δC (ppm) literature 
1ax 1.08 (1H, t, 10.8) 38.2 37.5 
1eq 1.85 (1H, dd,13.2, 3.7)   
2  1.17 (2H, t, 6.8) 26.9 31.8 
3 3.58 (1H, m)    79.9 79.1 
4 2.03 (2H) * 40.7 42.2 
5 - 144.4 140.1 
6 5.38(1H, t, 7.5) 122.7 122.1 
7 1.85 (2H) * 29.1 - 
8 1.36 (1H) * 51.2 - 
9 0.94 (1H) * 37.0 - 
10 - 37.6 36.6 
11  1.50 (2H) * 21.9 19.8 
12ax 2.25 (1H) * 39.5 38.7 
12eq 2.41 (1H) *   
13 - 43.2 42.2 
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14 1.12 (1H)* 57.0 56.7 
15 1.30 (2H)* 34.8 - 
16 1.60 (2H)* 28.1 28.1 
17 1.37 (1H)* 37.0 - 
18 0.68 (3H, s) 12.5 11.7 
19 1.00 (3H, s) 19.9 18.7 
20 1.08 (1H)* 57.8 - 
21 0.93 (3H, d, 6.4) 19.4 20.9 
22 1.98 (2H)* 34.8 - 
23 1.24 (2H)* 23.9 - 
24 1.67 (1H)* 30.1 - 
25  0.93 (1H)* 46.8 - 
26 0.83 (3H, d, 1) 19.4 19.2 
27 0.83 (3H, d, 1) 20.3 19.6 
28 1.27 (2H)* 23.5 24.8 
29 0.81 (3H, t, 1)* 19.5 - 
1′ 4.38 (1H, d, 7.8) 102.1 101.0 
2′ 3.18 (1H) 74.6 74.3 
3′ 3.39 (1H) 77.6 76.9 
4′ 3.36 (1H)  71.1 70.1 
5′ 3.27 (1H) 79.2 76.8 
6′ax 3.71 (1H) 62.5 62.3 
6′eq 3.84 (1H)   
* Undefined multiplicity due to overlapping,  
3.2.4 Structural elucidation of compounds p-hydroxyphenylethyl trans-ferulate (42) 
and p-hydroxyphenylethyl cis-ferulate (43) 
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42 
Compound 42 was isolated as a white powder from the branch extract of A. venosum. In the 
HR-ESI-(-)-MS spectrum (Figure 3.28) a quasi-molecular ion was observed at m/z 312.0996, 
corresponding to a molecular formula of C18H16O5 (calcd for C18H16O5, 312.0998).
  
 
Figure 3.28 HR-ESI-(-)-MS of compound 42 (400 MHz). 
 
Figure 3.29. 1H NMR spectrum of compound 42 in CD3OD (400 MHz). 
The 1H NMR spectrum (Figure 3.29) showed the two vinylic protons resonating at δH 6.40 
and δH 7.43. The coupling constant (J = 15 Hz) showed that the protons were in a trans 
conformation and the large difference in chemical shifts between the two resonances indicate 
 41 | P a g e  
 
that it is part of the α, β-unsaturated carbonyl moiety. Two pairs methylene protons resonating 
as triplets at δH 2.76 (H-7) and δH 3.47 (H-8) were observed in the spectrum. The downfield 
chemical shift (δH 3.47) (H-8) of one of the methylene protons showed that the methylene 
carbon is likely to be next to an electronegative atom (most likely oxygen). The phenyl region 
of the spectrum revealed a total number of seven aromatic protons when integrated. Two 
aromatic signals resonating at δH 6.72 (H-6) and δH 7.05 (H-5) as doublets integrated for two 
protons each, confirming the presence of a phenyl ring that is para-substituted. The remaining 
signals within the same region revealed the presence of the second phenyl ring. The other 
resonances in the aromatic region comprised doublet δH 7.12 d (J = 2 Hz, H-2’), doublet at δH 
6.79 d (J = 8 Hz, H-5’) and a doublet of doublets δH 7.02 dd (J = 8, 2 Hz, H-6’). A methoxy 
signal resonating at δH 3.88 as a singlet was also observed. 
The sample was left in the closed NMR tube dissolved in CD3OD solvent for six months by 
accident at room temperature (25C). It was analysed afterwards to check whether compound 
42 was still present or not. 1H NMR spectroscopy was performed on the sample, and it was 
observed that the initial compound 42 was still present but two sets of signals were observed 
(Figure 3.30), similar in multiplicity but different in intensities with slight chemical shift 
differences. The relative percentage of the trans-isomer was calculated to be 67 % using the 
1H NMR spectrum. Interestingly, the coupling constants of vinylic protons were different for 
the second set of signals. The J-value had changed from 15 Hz (trans-alkene) to 12 Hz (cis-
alkene). This showed that both compounds were similar with the only difference being the 
geometry the alkene bond (cis or trans) bond conformation of the alkene bond. 
 
Figure 3.30. 1H NMR spectrum of compound 42 (blue) and the mixture of cis (43) and trans-
isomers (red) in CD3OD (400 MHz). 
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Analysis of the 13C NMR and DEPT-135 spectra (Figure 3.31) and the HSQC (Figure 3.32) 
NMR spectra of the sample further confirmed the presence of two compounds. All resonance 
signals were assigned by correlating the protons with carbons using the HSQC NMR spectrum.  
 
Figure 3.31. 13C and DEPT-135 NMR spectrum of a mixture of 42 and 43 (100 MHz). 
For compound 42, a total of eighteen carbon signals were observed. A signal resonating 
downfield at δC 169.5 could be assigned to a carbonyl carbon of an ester group. Six quaternary 
carbon signals at δC 169.5, δC 157.1, δC 150.0, δC 148.7, δC 131.5, δC 128.5, assigned to C-9’, 
C-1, C-4’, C-3’, C-4 and C-1’, respectively, were also observed, which were in agreement 
with quaternary carbons of two phenyl rings. Two methylene signals were observed upfield 
resonating at δC 35.7 and δC 42.4, which correlated with the triplet signals observed in the 1H 
NMR spectrum (δH 2.76 and δH 3.47) respectively. The methoxy resonances for both the cis 
and trans-isomers were observed at δC 56.5 and 56.6 (C-10′), respectively. The alkene carbons 
could be assigned to two pairs of signals at δC 141.9 and δC 121.7 (trans) as well as δC 138.2 
and δC 118.9 (cis). The remaining signals downfield were assigned to the phenyl methine 
carbons, based on correlations observed in the HSQC spectrum (Figure 3.32).  
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Figure 3.32. HSQC NMR spectrum of compounds 42 and 43. 
The 1H-1H COSY (Figure 3.33) NMR spectrum displayed correlations in agreement with a cis- 
or trans-cinnamic acid derivative of 4-hydroxyphenyethyl ether. A 1H-1H COSY correlation of 
the phenyl protons is observed between, δH 7.02 and δH 6.79 as well δH 6.72 and δH 7.0, the 
methylene protons, δH 2.76 and δH 3.47 (yellow circles), and the trans-olefinic protons (purple 
circles) and the cis-isomer (orange circles). The observed correlations are illustrated in Figure 
3.34 
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Figure 3.33 COSY NMR spectra of compounds 42 and 43. 
 
Figure 3.34. Observed COSY correlations observed for compound 42. 
A final confirmation for the structures of 42 and 43 was obtained by the HMBC analysis 
(Figure 3.35). For the cis-isomer, the HMBC correlation of the two pair phenyl protons δH 6.68 
(H-6/2) and 7.00 (H-5/3) to carbons (δC 157.0, 116.6 and 131.4) (red circles) confirms the 
presence of a para-substituted phenol ring. Correlation of the methoxy protons (δH 3.83, H-10’) 
to the carbons δC 56.3 (C-10’) and δC 150.0 (C-4’) (yellow circles) as well as the HMBC 
correlation of aromatic protons (δH 7.35 (H-2’), 6.73 (H-5’), and 6.92 (H-6’) to the carbons 
resonating at δC 128.7 (C-1’), 114.1 (C-2), 149.5 (C-4’), and 124.8 (C-6’) and a cis-alkene 
carbon at δC 141.9 (C-7’) (purple circles) confirms the presence of a tri-substituted benzene 
ring. Another correlation of the methylene protons at H-8 and H-7 to carbons at δC 170.5 (C-
9’), δC 131.4 (H-1), δC 35.5 (C-7) and δC 42.2 (C-8) were observed (blue circles). Lastly, the 
HMBC correlation of the alkene and methylene protons was useful in connecting the phenyl 
rings, this correlation also shows the presence of an α,β-unsaturated ester subunit.  Similar 
correlations are observed for the trans isomer. Thus, compound 42 and compound 43 were 
identified to be 4-hydroxyphenylethyl 4-hydroxyphenylethyl trans-ferulate and 4-
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hydroxyphenylethyl cis-ferulate, respectively and are in good agreement with the literature.111 
The NMR data are collated in Table 3.4. 
 
 
Figure 3.35. HMBC NMR of compounds 42 and 43 
 
Figure 3.36. HMBC correlations observed for compounds 42 and 43. 
Since the sample was not in an acidic solution (acidic media normally promotes cis-trans 
isomerisation of alkenes), photo-isomerisation is the only reaction that could explain this 
phenomenon.112 This process only occurs in the presence of UV light which act as a source of 
photons. Because the sample was kept indoors, it had limited exposure to UV light. This type 
of reaction is considered to be non-reversable, thus explaining why the sample still contain ~67 
% of the trans compound after a long period of time, also (Scheme 3.1). 
 
Scheme 3.1. Photo-isomerisation of compounds 42 to 43. 
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Table 3.4. 1H (400 MHz) and 13C (100 MHz) NMR data of compounds 42 and 43 in CD3OD. 
Position δH (ppm) (J in Hz) δC (ppm)     
42* 43 42*     43 
1 - - 131.5 131.4 
2 6.72 (1H, d, 8.5) 6.68 (1H, d, 8.6) 116.6 116.6 
3 7.05 (1H, d, 8.4) 7.00 (1H, d, 8.4) 130.8 130.9 
4 - - 157.1 157.0 
5 7.05 (1H, d, 8.4) 7.00 (1H, d, 8.4) 130.8 130.9 
6 6.72 (1H, d, 8.4) 6.68 (1H, d, 8.6) 116.6 116.6 
7 2.76 (2H, t, 7.2) 2.69 (2H, t, 7.1) 35.7 35.5 
8 3.47 (2H, t, 7.2) 3.40 (2H, t, 7.5) 42.4 42.2 
1′ - - 128.5 128.7 
2′ 7.12 (1H, d, 1.8) 7.35 (1H, d, 1.9) 111.8 114.1 
3′ - - 148.7 148.6 
4′ - - 150.0 149.5 
5′ 6.79 (1H, d, 8.2) 6.73 (1H, d, 8.4) 116.4 116.0 
6′ 7.02 (1H, dd, 8.3, 1.9) 6.92 (1H, dd, 8.2, 1.8) 123.2 124.8 
7′ 7.43 (1H, d, 15.9) 6.61 (1H, d, 12.7) 138.2 141.9 
8′ 6.40 (1H, d, 15.9) 5.71 (1H, d, 12.6) 118.9 121.9 
9′ - - 169.5 170.5 
10′ 3.88 s 3.83 s 56.3 56.3 
 
3.3 Biological activity 
The stem and leaves crude extracts of A. venosum as well as loliolide (37), β-sitosterol 3-O-β-
D-glucoside (41) and p-hydroxyphenylethyl trans-ferulate (42) were assayed for antimicrobial 
activities against a Gram-positive (Staphylococcus aureus ATCC 12600), two Gram-negative 
(Pseudomonas aeruginosa ATCC 10145, Klebsiella pneumoniae ATCC 13883), and a drug-
resistant Gram-negative (Escherichia coli ATCC 25218) strains of bacteria. The crude extracts 
showed moderate but promising antimicrobial activity. However, pure compounds did not 
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show any antimicrobial activity (Table 3.5). The activity may be classified as significant (MIC 
< 100 µg/mL), moderate (100 < MIC ≤ 625) or weak (MIC > 625).113 
Table 3.5. Antibacterial activity results for A. venosum. 
 Antibacterial activity (MIC, µg/ml) 
 Gram +ve Gram -ve Drug resistant Gram -ve 
 S. aureus K. pneumoniae P. aeruginosa E. coli 
A. v/B 313 313 >5000 >5000 
A.v/L 1250 1250 >5000 >5000 
37 >500 >500 >500 >500 
41 >500 >500 >500 >500 
42 >500 >500 >500 >500 
Neomycin <0.24 0.98 0.98 0.24 
 
3.4 Conclusion 
The phytochemical investigation of the leaves of A. venosum led to an isolation of loliolide (37), 
lutein (38), pheophytin A (39), and pheophytin B (40). β-Sitosterol 3-O-β-D-glucoside (41) and 
4-hydroxyphenylethyl trans-ferulate (42) were isolated from the branches of A. venosum. These 
compounds have been isolated from of A. venosum for the first. These compounds are all known 
compounds and are occurring in several plant families. All compounds were identified as known 
compounds but are different from the previously isolated compounds from the plant species. 
The structures were confirmed by comparison of the NMR data with the literature data.Although 
known compounds, several of the compounds showed interesting biological activities as 
reported in the literature. The crude extracts showed promising antibacterial activities when 
assayed against Gram-positive (Staphylococcus aureus ATCC 12600) and Gram-negative 
(Pseudomonas aeruginosa ATCC 10145) bacteria but did not show any activity against a second 
Gram-negative (Klebsiella pneumoniae ATCC 13883) and a drug-resistant Gram-negative 
(Escherichia coli ATCC 25218) bacterial strain. The activity observed from by the crude extract 
may be due to the synergistic effect operating in the mixture or the unidentified active 
constituents present in the crude extract. The pure compounds did not show any activity.  
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3.5 Experimental  
3.5.1 General experimental procedure  
The extraction of the plant material was performed on an Infors AG CH-4103 Bottmingeni 
orbital shaker at room temperature. Mass spectra (LCMS and TOF-MS) were obtained on a 
Shimadzu LCMS 2020 and Water Micromass LCT Premier TOF-MS instrument using MS-
grade solvents (acetonitrile, methanol, water and formic acid). Both positive and negative 
ionisation modes were used for analysis.  
The NMR spectra of isolated compounds were recorded in CDCl3 (deuterated chloroform) and 
CD3OD (deuterated methanol) at 30 ºC using either a 5 mm BBOZ probe or a 5 mm TBIZ probe 
on Bruker Avance III (500 MHz for 1H, 125 MHz for 13C) and 400 (400 MHz for 1H, 100 MHz 
for 13C) spectrometers. Chemical shift (δ) signals are in units of parts per million (ppm) and are 
referenced to residual protonated solvent peak (CDCl3: 
1H 7.26, 13C 77.36 and CD3OD: 
1H 3.31, 
13C 49.03). Peak multiplicities are designated as s for singlet, d for doublet, t for triplet, q for 
quartet and m for multiplet. Coupling constants (J) are given in Hz. All solvents that were used 
in this research were of analytical grade. 
Column chromatography packed with silica gel (silica gel 60, 0.063-0.2000 mm, 70-230 Mesh 
ASTM) was used for initial fractionation, and centrifugal thin-layer chromatography, performed 
on circular glass plates (coated with preparative silica gel 60 PF254 containing gypsum, particle 
size ≤ 45 µm either 1 mm or 2 mm thickness) on a Chromatotron™, was used for the final 
purification of the compounds. For qualitative analysis of the fractions obtained and compounds 
isolated, thin-layer chromatography (TLC) (TLC silica gel 60 F254, aluminium-backed plates) 
with detection under long- or short-wavelength UV radiation (λ 254 and 365 nm, respectively) 
or staining with p-anisaldehyde reagent was used. The stain solution was prepared by putting a 
250 mL volumetric flask in an ice bath and add the following reagents sequentially, shaking the 
flask after each addition:  
 1 mL of p-anisaldehyde (98%) 
 20 mL of glacial acetic acid 
  170 mL of MeOH 
 4 mL of concentrated sulfuric acid  
All the reagents were added in a 250 mL volumetric flask, cooled in an ice bath. After 
preparation, the solution was stored in a fridge (4 ºC). 
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3.5.2 Plant material 
Leaves and stems of Antidesma venosum were collected in May 2017 at the Botanical Garden 
of the University of KwaZulu-Natal in Pietermaritzburg and was identified by the curator of the 
garden, Ms Alison Young. A voucher specimen was deposited in the Bews Herbarium, School 
of Life Sciences, UKZN (Voucher No 1. NU 0048865). 
3.5.3 Extraction and isolation of compounds 
The plant material (leaves and stems separately) of A. venosum were dried for two weeks at 
room temperature and then pulverised into a powder. Based on the literature published on the 
plant, it was decided that the leaves of A. venosum would be extracted with DCM and MeOH 
separately. The pulverised leaves (1 kg) was extracted exhaustively with DCM (48 h, room 
temperature). MeOH extraction of the leaves was omitted due to time constraints. The powdered 
stem material of A. venosum (1 kg) were extracted exhaustively with DCM-MeOH (1:1, v/v) 
(48 h, room temperature). The extracts were filtered through a cotton wool plug in a glass funnel. 
The filtrates were then concentrated under vacuum using a rotatory evaporator to obtain the 
crude extracts (13 g DCM leaf crude extract, 10 g DCM-MeOH stem crude extract). 
The DCM leaf crude extract was subjected to chromatography on a column packed with silica 
gel (14 x 3 cm) and eluted with a gradient method using a mixture of Hex and EtOAc as solvent 
systems: Hex (400 mL), Hex-EtOAc (9:1, 300 mL), Hex-EtOAc (7:3, 300 mL), Hex-EtOAc 
(1:1, 300 mL), Hex-EtOAc (3:7, 200 mL), Hex-EtOAc (1:9, 200 mL), then finally flushed with 
MeOH (200 mL) to yield 170 fractions (10 mL each. Fractions with similar TLC profiles were 
combined to afford ten fractions that were dried and weighed (Table 3.6).  
Table 3.6. Fractions obtained by column chromatography of the crude DCM extract of the 
leaves (A. venosum). 
Fraction Mass (g) Book code 
A 4 SSH-1-12A 
B 2 SSH-1-12B 
C 2 SSH-1-12C 
D 1 SSH-1-12D 
E 0.8 SSH-1-12E 
F 1 SSH-1-12F 
G 0.3 SSH-1-12G 
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H 0.1 SSH-1-12H 
I 0.6 SSH-1-12I 
J 0.1 SSH-1-12J 
 
Fractions 12A and 12B contained fats and oils and were not investigated further. Fractions 
12C, 12D, 12E and 12F were analysed further based on the TLC profiles. The rest of the 
fractions has too low a mass for further fractionation. Pheophytin A (39, 2 g) was isolated 
from fraction 12C and pheophytin B (40, 1 g) was isolated from fraction 12D. Fraction 12E 
and 12F were combined since a similar spot was observed in both fractions when analysed by 
TLC. The combined fraction was further fractionated by centrifugal chromatography (1 mm 
thick layer) using Hex-EtOAc (1:9) as the solvent system to yield loliolide (37) (5 mg) and 
lutein 38, 9 mg). 
 
Figure 3.37. Flow diagram of the isolation of compound 37, 41, 42 and 43. 
The DCM-MeOH crude extract of the stem (8 g) was applied to a column packed with silica 
gel (12 x 3 cm) and eluted with a mixture of DCM and MeOH as solvent systems: DCM (300 
mL), DCM-MeOH (9.5:0.5, 500 mL), DCM-MeOH (9:1, 300 mL), DCM-MeOH (8.5:1.5, 
200 mL). A hundred fractions (10 mL each) were collected, then finally flushed with MeOH 
(400 mL). A sticky sludge remained on the column and could not be eluted with MeOH. 
Distilled water mixed with 10 % of acetic acid was then used to elute out the sludge. The 
fractions were spotted on a TLC plate and viewed under long and short-wave UV lamps then 
stained with anisaldehyde. Fractions with similar TLC profiles were combined and dried 
afford ten fractions dried in the fume hood overnight and weighed (Table 3.7). 
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Table 3.7. Fractions obtained by column chromatography of the branch crude extract (A. 
venosum). 
Fraction 
Mass (mg) Book code 
A 38 SSH-1-37A 
B 109 SSH-1-37B 
C 452 SSH-1-37C 
D 54 SSH-1-37D 
E 61 SSH-1-37E 
F 16 SSH-1-37F 
G 26 SSH-1-37G 
H 125 SSH-1-37H 
I 90 SSH-1-37I 
J 
48 SSH-1-37J 
MeOH flush 
0 SSH-1-37k 
Sludge  
6 g  
 
Based on the TLC profile, fraction 37D was further fractionated on a small column (6 x 2 cm), 
with the eluting solvent system EtOAc-Hex (7:3). Five subfractions were obtained, and 
subfraction 38C was identified 4-hydroxyphenylethyl trans-ferulate (42, 5 mg). Fraction 37J 
was fractionated further with a small column (6 x 2 cm), and the eluting solvent system used 
was DCM-MeOH (8:2), four subfractions were obtained. Of the four subfractions, subfraction 
27B was analysed and identified to be β-sitosterol 3-O-β-D-glucoside (41, 14 mg). (Figure 
3.38). 
3.5.4 Biological assay 
Preparation of Microorganisms  
The bacteria used in this study were one Gram-positive (Staphylococcus aureus ATCC 12600), 
two Gram-negative (Pseudomonas aeruginosa ATCC 10145, Klebsiella pneumoniae ATCC 
13883), and one drug-resistant Gram-negative (Escherichia coli ATCC 25218) bacterial 
strains. Preserved cultures of bacteria on Mueller Hinton Agar (MHA) slants at 4 °C were used 
as stock cultures throughout the study. 
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Figure 3.38. Flow diagram of the isolation of compound 38 and 40. 
 
Minimum Inhibitory Concentration (MIC) determination  
A rapid p-iodonitrotetrazolium chloride (INT) colourimetric assay was used to determine the 
MIC (minimum inhibitory concentration) values of samples against the bacterial strains.114 
Samples of extracts and isolated compounds (100, 50, and 10 mg/mL) were prepared in DMSO. 
Stock solutions of samples were initially diluted to concentrations of 20, 5 and 2 mg/mL with 
sterilised distilled water. The samples were then mixed with Mueller Hinton Broth (MHB), and 
sequentially diluted 2-fold in a 96-well-microplate to a final concentration range of 5000 – 39  
and 500 – 3.9 µg/mL, for the extracts and single compounds, respectively. Bacterial strains 
were cultured overnight at 37 °C on MHB and adjusted to a final density of 106 cfu/mL with 
MHB. These were used as inocula. An inoculum of 100 µL was added to each well (200 µL). 
The plates were covered with a sterile plate sealer and then incubated at 37 °C for 20 h. 
Neomycin was used as a positive control while wells containing 10% DMSO, MHB and 100 
µl of inoculum served as the negative controls. The MICs of samples were observed after 20 h 
of incubation at 37 °C, followed by 30 min of incubation after the addition 40 µl of 0.2 mg/mL 
INT. The inhibition of bacterial growth would be indicated by clear wells with INT after 
incubation. Minimum inhibitory concentration (MIC) values were recorded as the lowest 
concentration of the sample that completely inhibited bacterial growth. The results are given 
in Table 3.5. 
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3.5.5 Physical data of isolated compounds 
Loliolide (37) was isolated as a white powder. 1H and 13C NMR data are collected in Table 3.1. 
HR-ESI-(+)-MS, m/z 219.0992 (calcd for C11H16O3Na, 219.0997). 
Lutein (38) was isolated as an orange powder. 1H and 13C NMR data are collected in Table 
3.2. HR-ESI-(-)-MS, m/z 567.4180 (calcd for C40H55O2, 567.4202). 
Pheophytin A (39) was isolated as a dark solid. 13C NMR (400 MHz, CDCl3) δC 189.6 (C-13′), 
δC 172.9 (C-17′′′), δC 172.2 (C-19), δC 169.6 (C-13′′′), δC 161.2 (C-16), δC 155.6 (C-6), δC 150.9 
(C-9), δC 149.7 (C-14), δC 145.17 (C-8), δC 142.8 (C-p3), δC 142.0 (C-1), δC 137.9 (C-7), δC 
136.5 (C-3), δC 136.3(C-4), δC 136.2(C-7), δC 131.8 (C-2), δC 129.1(C-3′), δC 129.0 (C-12), δC 
128.9 (C-13), δC 122.7 (C-3′′), δC 117.8 (C-p2), δC 105.3 (C-15), δC 104.4 (C-10), δC 97.5(C-5), 
δC 93.1 (C-20), δC 64.7 (C-13′′), δC 61.5 (C-p1), δC 52.8 (C-13′′′), δC 51.2 (C-17), δC 50.1 (C-
18), δC 39.8-24.1 (C-p4-p14), δC 31.2 (C-17′′), δC 29.8 (C-17′), δC 27.9 (C-p15), δC 23.1 (C-18′), 
δC 22.7 (C-p16), δC 22.6 (C-p15′), δC 19.7 (C-p11′), δC 19.6 (C-p7′), δC 19.4 (C-8′), δC 17.4 (C-
8′′), δC 16.2 (C-p3′), δC 12.1 (C-12′), δC 12.0 (C-2′), δC 11.2 (C-7′). HR-ESI-(+)-MS, m/z 
893.5536 [M+Na]+ (calcd for C55H74N4O5Na, 893.5557). 
Pheophytin B (40) was isolated as a brown solid. 1H NMR (400 MHz, CDCl3) δH 9.39, δH 9.49 
and δH 8.55 are observed. 13C NMR (400 MHz, CDCl3) δC 12.2 (C-12′), 14.1 (C-17′′), 16.3 (C-
p3′), 19.1 (C-7), 19.3 (C-8′′), 19.6 (C-8′), 19.7 (C-11′′), 22.6 (C-p15′), 22.7 (C-p16), 23.0 (C-
18′), 24.4 (methylenes), 24.7 (methylenes), 25.0 (methylenes), 27.9 (C-p15), 29.7 (C-17′′), 31.2 
(C-13′), 31.9 (methylenes), 32.6 (C-p5), 32.7 (methylenes), 36.6 (methylenes), 37.3 
(methylenes), 37.4 (methylenes), 39.3 (methylenes), 39.7 (C-p4), 50.1 (C-18), 51.4 (C-17), 
52.9 (C-13′′), 61.5 (C-13′′), 64.6 (C-17′′), 93.3 (C-20), 101.6 (C-5), 105.0 (C-10), 106.9 (C-
15), 123.5 (C-3′′′), 128.6 (C-12), 129.7 (C-3′), 132.4 (C-13), 132.9 (C-2), 137.1 (C-3), 137.7 
(C-4), 138.0 (C-11), 143.5 (C-1), 147.1 (C-8), 150.7 (C-9), 151.2 (C-141), 159.3 (C-6), 164.0 
(C-16), 169.3 (C-19), 172.8 (C-13′′), 174.0 (C-17′′CO2), 187.6 (C-7′), 189.5 (C-13′).  
β-Sitosterol 3-O-β-D-glucoside (41) was isolated as a yellow-white solid. 1H and 13C NMR 
data are collected in Table 3.3. HR-ESI-(-)-MS, m/z 611.4071 (calcd for C35H60O6Cl, 
611.4078) 1H and 13C NMR data are collected in Table 3.3. 
4-Hydroxyphenylethyl trans-ferulate (42) was isolated as a white powder. 1H and 13C NMR 
data are collected in Table 3.4. HR-ESI-(-)-MS m/z 312.0996 (calcd for C11H18O5, 312.0998). 
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CHAPTER 4 
Phytochemistry of Euphorbia cooperi N.E.Br. ex A.Berger 
 
4.1 Introduction 
4.1.1 Euphorbia subg. Euphorbia (E. subg. Euphorbia)   
Euphorbia L. is the largest genus of the Euphorbiaceae with over 2000 species and has a 
worldwide distribution and is diverse in arid and semiarid regions of the tropics and subtropics. 
Euphorbia genus consists of four subgenera namely E. subg. Esula Pers., E. subg. Rhizanthium 
(Boiss) Wheeler, E. subg. Chammaesyce Raf., and E. subg. Euphorbia. Of these four 
subgenera, Euphorbia subgenera Euphorbia (E. subg. Euphorbia) is the largest and most 
morphologically diverse subgenus.115-116 It includes herbs, geophytes, woody shrubs, 
understory and canopy tree, and the unusual growth of pencil-stemmed plants (e.g. E. decorsei, 
Figure 4.1. P). Woody shrubs and trees occur in both xeric and mesic forests of Madagascar 
and New World Tropics. Herbaceous species are found in South America, Africa, and 
Australia. Geophytes have evolved several times in E. subg. Euphorbia and are in Africa, 
Madagascar, the Arabian Peninsula, and South Asia.115  
Plant species of this subgenus have succulent stems and branches, with sharp thorns on the base 
of each leaf. The stipules modified as prickles can be as large as the spines but can also smaller 
and sometimes apparently obsolete. In the leaf-axil, is the flowering-eye, from which the 
inflorescence grows consisting of a singular dichasial cyme. Some Madagascan species 
developed apparently similar horny structures bearing one or more “spines”, but these are 
modified stipules, each with an expanded horny base that flanks the leaf-scar but does not 
surround it. In related species these stipule structures are often developed into bristly fringes 
(Figure 4.1).117 
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https://xavieraubriot.files.wordpress.com/2015/06/dorsey-et-al-2013.pdf  
Figure 4.1. Examples of growth from of morphological diversity in Euphorbia subgenus. A, 
E. floridana; B, E. hedyotoids; C, E. cooperi; D, E. nana; E, E. horombensis; F, E. decorscei. 
G, E. sect.Euphorbia; H,  E.sect. Goniostema; I, E. Crepidara; J, E. sect. Monodenium, E. 
heptropoda; K, E. sect. Brasilinses; L, E.sect.Goniostema; M, E. sect.vigureri; N, E. sect. 
Euphorbia, E. zoutpansbergeni; O, E. sect. Goniostema; P, E. neospinescens. 
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4.1.2 Euphorbia cooperi N.E.Br. ex A.Berger 
Euphorbia cooperi N.E.Br. ex A.Berger (Figure 4.2), also known as bushveld candelabra 
Euphorbia (Eng) and noorsdoring (Afrikaans),44 is a single-crowned, green, and succulent 
spiny tree that grows up to 10 m in height. It consists of branches that are restricted to the upper 
section of the tree with branch scars clearly visible along the length of the stems. These 
branches have multiple wing-like angles with segmentation along the shape of an inverted heart 
with the widest section near the base of the segment that tapers to its apical part. E. cooperi is 
native to Mozambique, the eastern parts of South Africa, south Zimbabwe, Swaziland and 
Zambia. Its variability mainly depends on habitat, geology, and climate.118-119 
 
Figure 4.2. Euphorbia cooperi N.E.Br. ex A.Berger. 
There are three different  subtypes of E. cooperi, namely E. cooperi var. cooperi, which occurs 
in South Africa, E. cooperi var. ussanguensis (N.E.Br) L.C Leach, which is distributed in 
Mozambique, Zimbabwe, Malawi and Zambia, and E. cooperi var calidicola L.C. Leach, found 
in Tanzania and Zambia.118  
The E. cooperi latex is considered to be very poisonous and any contact with the skin, eyes or 
mouth will cause severe pain and may lead to blindness.120 A search of the literature revealed 
that there are four reports on the phytochemistry of E. cooperi51,120-122 and one report on the 
cytotoxicity of the plant extract.84 According to the phytochemical reports, five compounds 
were isolated from E. cooperi N.E.Br., three phorbol-type diterpenoid esters, 12-deoxyphorbol 
13-angelate-16-isobutyrate-20-acetate (43),121 12-deoxyphorbol 13-angelate-16-isobutyrate 
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(44),121 12-deoxyphorbol-13-isobutyrate-16-angelate-20-acetate (45), and two triterpenoids, 
euphol (20), and obtusifoliol (46).120 
 
Despite the toxicity associated with Euphorbia diterpenoids, recent research has showed that 
some of these compounds have a remarkable bioactivity, e.g. the phorbol ester prostratin (13) 
which in the process of being developed in an anti-HIV drug and ingenol 3-angelate (15), which 
has been approved as an anti-cancer drug. As a result, we decided to reinvestigate the 
phytochemistry of E. cooperi.  
4.3 Results and discussion 
The aerial parts of E. cooperi were extracted with DCM-MeOH (1:1, v/v) to afford a crude 
extract that were subjected to vacuum liquid chromatography (VLC) on silica gel and eluted 
using mixtures of Hex, DCM, EtOAc, and MeOH. The fractions were purified by column 
chromatography and centrifugal thin-layer chromatography to afford compounds 47 - 51. The 
structures were elucidated by spectroscopic analysis including 1H NMR, 13C NMR, DEPT-
135, COSY, HSQC, HMBC and TOF-MS. The structures of the known compounds were 
confirmed by comparison of the NMR data with those reported in the literature.  
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4.3.1 Structural elucidation glutinol (47) 
 
47 
Compound 47 was isolated as a white powder. In the HR-ESI-(+)-MS spectrum (Figure 4.3), a 
protonated molecular ion was observed at m/z 427.3948, corresponding to a molecular formula 
of C30H50O (calcd for the protonated molecular ion C30H51O, 427.3940).
   
 
Figure 4.3. HR-ESIMS (positive mode) of compound 47. 
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Figure 4.4. 1H NMR spectrum of compound 47 in CDCl3 (400 MHz). 
In the 1H NMR spectrum of 47 (Figure 4.4), a doublet at δH 5.62 (H-6) with a coupling constant 
of J = 5.9 Hz was observed. The chemical shift of the proton was in agreement with an alkene 
proton. At δH 3.46 (H-3), a triplet with a coupling constant J = 2.6 Hz was observed and the 
chemical shift of this signal indicated that the proton was most likely attached on an oxygen 
bearing carbon. The small coupling constant showed that this proton might be in an equatorial 
position in a six-membered ring in the chair conformation. According to the Karplus equation, 
which states that the diaxial protons with a dihedral angle of 180° will have a large coupling 
constant, (ca. J = 11 Hz), protons with an axial-equatorial or equatorial-equatorial relationship 
with a dihedral angle of 60° will have a smaller coupling constant. Therefore, since J = 2.6 Hz, 
the protons on C-2 and C-3 have a dihedral angle close to 60°, meaning that the hydroxy group 
(OH) is in an axial position in a six-membered ring in a chair conformation (Figure 4.5). the 
COSY NMR spectrum is provided in the Addendum (Plate 9) 
 
Figure 4.5. COSY correlation observed for compound 47. 
 A large number of protons were observed in the region δH 1.23-2.07. These protons had 
complex splittings and overlapped substantially and were difficult to analyse. In the high-field 
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region eight singlets, which all integrated for three protons each, were observed. These were 
in agreement with eight methyl groups of a triterpenoid structure. 
 
Figure 4.6. 13C and DEPT-135 NMR spectra of compound 47 in CDCl3 (100 MHz). 
The 13C NMR and DEPT-135 NMR spectra (Figure 4.6) and the HSQC spectrum (Figure 4.7) 
of compound 47 showed the presence of 30 carbon signals: 7 quaternary carbons, 5 methine 
carbons, 11 methylene carbons and 8 methyl carbons. The carbon signals resonating at δC 141.6 
and δC 122.1 were assigned to carbons at position 5 and 6 of an alkene system. The signal at δC 
76.3 was assigned to an oxygen bearing carbon. The COSY spectrum of 47 is given in the 
Addendum 
 
Figure 4.7. HSQC NMR spectrum of compound 47. 
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The correlations observed in the HMBC spectrum (Figure 4.8) between the methyl protons 
and adjacent carbon resonances were crucial in constructing the triterpene structure. The 
methyl proton resonances at δH 1.13 (H-23) and 1.03 (H-24) both correlated to carbon signals 
at δC 141.6 (C-5), 76.3 (C-3) and 40.8 (C-4), as well as to each other, were assigned to the C-
23 and C-24 of a triterpenoid. The methyl singlet at δH 0.84 showed correlations to carbons at 
δC 49.7 (C-10), δC 34.9 (C-9) and δC 47.5 (C-8) and was assigned to 25-Me. The methyl proton 
signal at δH 1.09 (26-Me) showed correlation to a carbon resonances at δC 47.5 (C-8), δC 32.1 
(C-15) and δC 39.3 (C-13), the methyl proton signal at δH 1.00 (27-Me) to the carbon resonances 
at δC 30.4 (C-12), δC 39.3 (C-13) and δC 43.1 (C-18), and methyl proton signal at δH 1.16 (28-
Me) to the carbon resonances at δC 30.1 (C-17) and δC 43.1 (C-18) (Figure 4.7). 
 
Figure 4.8. HMBC NMR spectrum of compound 47. 
Thus, the structure of compound 47 was identified as glutinol and the spectroscopic data were 
in agreement with the literature values. The NMR data are collated in Table 4.1.123-124 
Glutinol is a nonpolar pentacyclic triterpenoid that is known to have anti-inflammatory and 
analgesic activities.123-124 This compound has been isolated from plant species including 
Euphorbia species. But has not been reported in E. cooperi.  
Table 4.1 1H (400 MHz) and 13C (100 MHz) NMR data for compound 47 in CDCl3. 
Position δH (ppm) (J in Hz) δC (ppm)  δC (ppm) 
1 1.23-2.32 (m) 18.2 18.2 
2 1.23-2.32 (m) 27.8  
3 3.46 (1H, t, 2.8) 76.3 76.4 
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4 - 40.8 40.8 
5 - 141.6 141.6 
6 5.62 (1H, brd, 5.5) 122.1 120.1 
7 1.23-2.32 (m) 23.6 23.7 
8 1.23-2.32 (m) 47.5 47.5 
9 - 34.9 34.9 
10 - 49.7 49.7 
11 1.23-2.32 (m) 34.6 32.1 
12 1.23-2.32 (m) 30.4 27.8 
13 - 39.3 39.3 
14 - 37.8 37.9 
15 1.23-2.32 (m) 32.1 30.4 
16 1.23-2.32 (m) 36.0 34.6 
17 - 30.1 30.1 
18 1.23-2.32 (m) 43.1 43.1 
19 1.23-2.32 (m) 35.1 35.1 
20 - 28.2 28.2 
21 1.23-2.32 (m) 33.1 33.1 
22 1.23-2.32 (m) 39.0 39.0 
23 1.13 (s) 25.4 25.5 
24 1.03 (s) 29.1 29.0 
25 0.84 (s) 16.2 16.2 
26 1.09 (s) 19.6 19.6 
27 1.00 (s) 18.4 18.4 
28 1.16 (s) 32.0 32.0 
29 0.94 (s) 34.5 34.5 
30 0.98 (s) 32.4 32.4 
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4.3.1 Structural elucidation of compounds 48 and 49 
 
48 
 
Figure 4.9. 1H NMR spectrum of compound 48 in CDCl3 (400 MHz). 
The 1H NMR spectrum of compound 48 (Figure 4.9) showed two olefinic signals resonating 
downfield at δH 5.81(H-8) and δH 5.72 (H-7) as doublets of doublets. Tshe coupling constant 
(J = 15.3 Hz) was characteristic of a trans-alkene. The multiplicities (dd) also indicated that 
both the alkene carbons are adjacent to methine carbons. Two pairs of diastereotopic protons 
resonating at δH 2.16 (1H, dd, J = 13.8 and 6.7 Hz, Heq) and δH 1.62 (1H, m, Heq), as well as δH 
1.84 (1H, dd, J = 13.1 and 6.8 Hz, Heq) and δH 1.58 (1H, m Heq) were observed. In the COSY 
spectrum (Figure 4.10), a broad multiplet at δH 3.96 correlated with the two pairs of 
diastereotopic methylene protons.  Three methyl signals resonated upfield, two as singlets and 
one as a doublet at δH 1.35 (s), δH 1.10 (s), and δH 1.29 (d), respectively 
 64 | P a g e  
 
. 
 
Figure 4.10. COSY NMR spectrum of compound 48 
 
 
Figure 4.11. 13C and DEPT-135 NMR spectra of compound 48 (100 MHz). 
Figure 4.11 shows a total of 13 carbon signals for compound 48. Three quaternary carbons 
resonating at δC 179.2, δC 85.3 and δC 46.3, five methine carbons at δC 142.2, δC 120.6, δC 68.0, 
δC 65.2 and δC 57.7, two methylene carbons at δC 38.0 and δC 36.2, and three methyls at δC 
23.7, δC 23.4 and δC 18.9, were observed. The two carbon signals resonating at δC 142.2 and δC 
120.6 were assigned to two olefinic carbons. The signal at δC 179.2 was assigned to a carbonyl 
carbon, corresponding to an ester carbonyl. The chemical shift was higher than is normally 
observed for an ester carbon, but this can be attributed to the strained ring system in the 
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compound. The chemical shifts of the methine signals at δC 68.0 and δC 65.2 indicated the 
attachment of an electronegative atom on the methine carbons, most likely oxygen. The carbon 
signals were correlated to the 1H NMR signals using a HSQC NMR spectrum (Figure 4.12). 
 
Figure 4.12. HSQC NMR spectrum of compound 48. 
The final structure of 48 was based on the HMBC NMR spectrum (Figure 4.13 and 4.14). In 
the spectrum, correlations between the olefinic proton at δH 5.81 and the methyl carbon at δC 
23.7 as well as the methine carbon at δC 68.0 confirmed that the alkene system is attached to a 
methine carbon bearing an oxygen and a methyl group. The HMBC correlations of the other 
olefinic proton to a methine carbon signal at δC 57.7 confirms that the olefin system is also 
attached to a second methine carbon. The presence of the lactone ring was confirmed by the 
HMBC correlations between the carbonyl carbon and one of the methyl proton singlets as well 
as the enantiotopic protons in the axial position. Based on the NMR data, structure 48 was 
assigned to this compound. The NMR data are collated in Table 4.2. The absolute and relative 
configuration of this compound needs to be confirmed by further studies.   
 
Figure 4.13 HMBC NMR spectrum of compound 48 (green circle – please see Figure 4.14) 
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Figure 4.14. HMBC NMR spectrum of compound 48 
 
49 
An extensive search of literature revealed only one compound with a framework similar to 48, 
cucubalactone (49).124 The only difference was the presence of the hydroxy group at position 
C-6, thus compound 48 was regarded as novel and we named it euphorbilactone. Related 
bicyclic norsesquiterpenes (euphorbiosides A and B) were isolated from Euphorbia 
resinifera.125 Cucubalactone was isolated from Arachis hypogaea (Fabaceae, the plant that 
produce peanuts). Further investigation of the crude extract of E. cooperi led to the isolation 
of another known norsesquiterpenoid, arachiside A (50). 
 67 | P a g e  
 
 
50 
Compound 50 was isolated as a yellow oil. In the HR-ESI-(+)-MS spectrum (Figure 4.15), a 
sodium adduct was observed at m/z 425.1793, corresponding to a molecular formula of 
C19H30O9 (calcd for C19H30O9Na, 425.1788).
   
 
Figure 4.15. HR-ESI-(+)-MS (positive mode) of compound 50. 
The 1H NMR spectrum of compound 50 (Figure 4.16) showed similar signals to those of 
compound 48. Two olefinic signals resonated downfield at δH 5.77 and δH 5.47 as doublet of 
doublets. The coupling constants indicated that they were alkene protons in a trans 
conformation. The multiplicity (dd) also showed that each of the alkene carbons was being 
neighboured by a methine carbon. The equatorial protons of two pairs of diastereotopic 
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protons were also observed at δH 2.28 (1H, dd, J = 14 and 7 Hz, Heq) and δH 1.90 (1H, dd, J = 
13 and 7 Hz, Heq). The axial proton signals overlapped between δH 1.77 and δH 1.70. Three 
methyl signals resonated upfield, two as singlets and one as a doublet at δH 1.36 (s), δH 1.08 
(s) and δH 1.25 (d), respectively. The change in chemical shift of the diastereotopic signals and 
the proton at position C-5 suggested that there was an additional group bonded to the oxygen. 
Additionally, a O-glucosidic anomeric proton was observed as a doublet at δH 4.35, the 
coupling constant (J = 7.9 Hz) suggested that the proton is in the β-position. Based on the 
signals observed in the glucosidic region, the change in chemical shifts of the diastereotopic 
signals when compared to those of compound 48, and the presence of a β-anomeric proton 
being observed in the 1H NMR spectrum of compound 50, it was concluded that a β-D-glucose 
moiety was attached at to C-3 of the compound. This was further confirmed by the long-range 
HMBC (Figure 4.17) correlations of an anomeric proton of the glucose moiety to the carbon 
at position C-3, further confirming the presence of an O-glucosidic bond. In the 1H NMR 
spectrum the carbohydrate signals are overlapping but the 13C NMR chemical shifts were in 
agreement with a glucose moiety. The rest of the correlations observed in the HMBC spectrum 
as well as the COSY (Plate 10, Addendum), and HSQC NMR spectra (Plate 11) confirmed 
the proposed structure. Thus compound 50 was identified to arachiside A.126 The NMR data 
are collated in Table 4.2 
 
Figure 4.16. 1H NMR spectrum of compound 50. 
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Figure 4.17. HMBC spectrum of compound 50. 
Arachiside A is a glucoside derivative of a norsesquiterpenoid, euphorbilactone (48). This 
compound has been isolated only once prior to the study, from Arachis hypogaea, the plant 
that produces peanuts. Both 48 and 50 are derived from degradation of carotenoids such as 
lutein (37)127 (Scheme 4.1). 
 
Scheme 4.1. Proposed biosynthetic pathway of compounds 48 and 50 
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Table 4.2. 1H (400 MHz) and 13C (100 MHz) NMR data for compounds 48 in CDCl3 
and 50 in CD3OD. 
Position 
δH (ppm, J in Hz) 
δH (ppm, J in Hz) δC (ppm) δC (ppm) 
 
48 50 48 50 
1 
- 
- 46.3 47.7 
2ax 1.84 (1H, dd, 6.8, 13.1) 1.90 (1H*) 
36.2 36.1 
2eq 1.58(1H, dd*) 1.70-1.77(1H*) 
3 3.96 (1H, m) 3.97 (1H, m) 65.2 73.6 
4ax 2.16 (1H, dd, 6.7, 13.8) 2.28 (1H*) 
38.0 35.8 
4eq 1.62 (1H, dd*) 1.70-1.77(1H*) 
5 - - 85.3 86.9 
6 2.36 (1H, d, 9.2) 2.47 (1H, d, 9.0) 57.7 59.0 
7 5.72 (1H, dd, 9.2, 15.5) 5.77 (1H, dd, 9.2, 15.8) 120.6 121.9 
8 5.81 (1H, dd, 5.1, 15.3) 5.85 (1H, dd, 5.4, 15.2) 142.2 143.9 
9 
4.36 (1H, q, 6.0) 4.30 (1H, m) 68.0 68.9 
10 1.29 (3H, d, 8.9) 1.25 (3H, d, 6.5) 23.7 23.9 
11 - - 179.2 181.5 
12 
1.10 (3H, s) 1.08 (3H, s) 18.9 19.4 
13 
1.35 (3H, s) 1.35 (3H, s) 23.4 23.8 
1′ 
- 4.35 (1H, d, 7.9) - 103.1 
2′ 
- 3.14 (1H, t, 8.4) - 75.2 
3′ 
- 3.26-3.53 (1H*) - 78.2 
4′ 
- 3.26-3.53 (1H*) - 71.7 
5′ 
- 3.26-3.53 (1H*) - 78.0 
6′ 
- 3.66 - 
62.7 
- 3.83 - 
*undefined 
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4.3.4 Structural elucidation of compounds 51 and 52 
 
51 
Compound 51 was isolated as a yellow oil. In the HR-ESI-(+)-MS spectrum (Figure 4.18) a 
sodium adduct was observed at m/z 553.2411, corresponding to a molecular formula of 
C29H39O9 (calcd for C29H39O9Na, 553.2414).
   
 
Figure 4.18. HR-ESI-(+)-MS of compound 51. 
 
Figure 4.19. 1H NMR spectrum of compound 51 in CDCl3 (400 MHz) 
The 1H NMR spectrum of compound 51 (Figure 4.19) showed an aromatic proton resonating 
as a broad singlet at δH 7.65. One olefinic signal resonating as a singlet at δH 6.90 was observed. 
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Two pairs of doublets resonating at δH 4.05 and δH 4.18 as well as δH 4.25 and δH 4.36 were also 
observed, each integrated for one proton. The signals were assigned as two methylene protons 
using the HSQC NMR spectrum (Figure 4.20), which were attached to an electronegative 
atom, most likely oxygen, based on the 1H NMR chemical shifts.  
 
Figure 4.20. HSQC NMR spectrum of compound 51. 
The observed NMR signals resembled those of phorbol esters. A pair of doublets overlapping 
at δH 1.15, which integrate for six protons, i.e two methyls, were easily assigned to the 
isobutyrate moiety, further confirmation of the group was obtained by the long-range HMBC 
(Figure 4.21) correlations of both the methyls to a carbonyl carbon resonation at δC 179.0, an 
ester carbonyl. Assigning the position of the isobutyrate group was difficult, as there were no 
HMBC correlations of the core phorbol protons to this carbonyl carbon. A comparison with the 
literature data of phorbol esters revealed that the isobutyrate group was attached to a quaternary 
carbon C-13. Signals resembling an angelate moiety were observed in the 1H NMR spectrum: a 
broad triplet at δH 1.88 and a doublet of doublets at δH 1.96, corresponding to the two methyls, 
and a signal resonating as a quartet of doublets at δH 6.07, corresponding to the methine proton. 
The chemical shift of the methine proton indicated that it was an olefinic methine, further 
confirming the presence of an angelate group. The attachment of the angelate group at C-16 is 
based on the HMBC correlation between two diastereotopic protons on C6 (δH 4.05 and δH 4.18) 
and the resonance at C-1''' (167.9). In the seven-membered ring of the phorbol ester, the presence 
of an α,β-unsaturated carbonyl ketone (δC 201.4). The position of the double bond the terminal 
methanol group, was observed by an extensive comparison of NMR data with the literature data 
of similar phorbol esters as well as the HMBC correlations between the methylene protons to 
both the carbonyl and the olefinic carbons. The rest of the signals and correlations were in 
agreement with the phorbol ester, 16-angeloyloxy-13α-isobutanoyloxy-4β,9α,20-
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trihydroxytiglia-1,5-diene-3,7-dione, which was recently isolated from Euphorbia 
grandicornis.128 
 
Figure 4.21. HMBC spectrum of compound 51.   
 
52 
Compound 52 was isolated as a yellow oil. In the HR-ESI-(+)-MS spectrum (Figure 4.22) a 
sodium adduct was observed at m/z 595.2545, corresponding to a molecular formula of 
C31H40O10 (calcd for C31H40O10Na, 595.2519).
   
 
Figure 4.22. HR-ESI-(+)-MS of compound 52. 
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Figure 4.23. 1H NMR spectrum of compound 52. 
The 1H NMR spectrum of compound 52 (Figure 4.23) showed signals which were similar to 
those of compound 51. Most of the signals resembled the signals of a tigliane phorbol ester. 
Proton signals resonating at δH 7.60 and δH 6.28 could be assign to the olefinic protons at 
position C-1 and C-5 of a phorbol ester. The appearance of H-5 at δH 6.28 for 52 compared to 
H-5 at δH 6.90 for 51 is due to the electronic effects contributed by the hydroxyl and the 
carbonyl groups attached at position C-20. The hydroxyl is an electron donating group when 
compared to the carbonyl group, thus the signal for H-5 of 51 will be slightly downfield 
(deshielded) and the signal for H-5 of 52 will be slightly upfield (shielded). The presence of an 
angelate and an isobutyrate moieties were also confirmed by the comparison of the 1H NMR 
data with compounds 51. For compound 52, an additional singlet resonance, integrated for 
three protons, at δH 2.08 was observed. This signal was assigned to an acetate methyl group. A 
slight shift of signals is also observed, especially the signals of the protons on the seven-
membered ring when compared to compound 51. Additionally, one proton signal was observed 
at δH 4.82, the chemical shift indicated that it was attached to an oxygen-bearing carbon. In the 
COSY NMR spectrum (Figure 4.25) the proton (δH 4.82) correlated to a proton resonating at 
δH 2.66, assigned to H-8.  
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Figure 4.24. HSQC NMR spectrum of compound 52. 
 
Figure 4.25. COSY NMR spectrum of compound 52. 
The HMBC (Figure 4.26) revealed that region highlighted in red was different from compound 
51. At position C-7 there was hydroxy group, based on the HMBC correlations of the proton 
resonating at δH 4.82 to the carbons at δC 147.4 (olefin quaternary carbon), δC 72.8 (oxygen-
bearing carbon), δC 45.2 (methine carbon). At position C-20, an acetate group was attached. 
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Figure 4.26. HMBC spectrum of compound 52. 
The configuration at position C-7 of the molecule was confirmed using the NOESY-NMR 
experiment (Figure 4.27). A correlation of the proton to the proton at position C-10 of the 
molecule confirmed that the proton at position C-7 of compound 52 is facing away, in the same 
plain as H-10. The coupling constant between H-7 and H-8 (J = 9.4 Hz) is characteristic of 
protons in a diaxial orientation. Thus, the structure of 52 was assigned as 20-acetoxy-16-
angeloyloxy-13α-isobutanoyloxy-4β,7β,9α,20-tetrahydroxytiglia-1,5-diene-3-one. The NMR 
data of 51 and 52 are collated in Table 4.3. 
 
Figure 4.27. NOESY NMR spectrum of compound 52. 
An extensive literature search revealed that 52 is a new phorbol ester. The only related compound is 
was isolated from Euphorbia grandicornis with a ketone at position C-7 and without an acetate group 
at C-20.128 Compounds 51 and 52 are classified as tigliane phorbol esters. In all the other phorbol 
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esters, the double bond is between C-6 and C-7, whereas with 51 and 52, the double is between C-5 
and C-6. The tigliane-type phorbol esters have a remarkable biological activity. The activity is 
associated with activation of protein kinase C and other structurally similar phorbol esters. These 
compounds mimic the action of diacyl glycerol, an activator of protein kinase C. The structural 
variation between C-3 and C-7 determines the activity of a compound.  
Compound 51 was isolated once from Euphorbia grandicornis and no biological assays were 
conducted on it. As explained in the literature review (Chapter 2.2), tigliane phorbol ester are 
distributed in the Euphorbiaceae and Thymelaeaceae families. This class of diterpenoids possess the 
most exciting and diverse useful biological activities, including anti-HIV, tumour-promoting, skin 
irritant, cytotoxic, and proinflammatory activities. Compound 51 and 52 are structurally similar to 
both prostatin (13) and ingenol 3-angelate (15) and it can be concluded that compound 51 may have 
useful biological potential as a protein kinase C activators and modulators of the TRPV4 receptor. It 
would be interesting to evaluate the biological activity of 51 and 52, as the position of the double 
bond is unique from all known tigliane phorbol esters. Both compounds (51) and (52) have a 12-
deoxy six-membered ring, so it can be concluded that both compounds should not be tumour 
promoters.  
Table 4.3. 1H (400 MHz) and 13C (100 MHz) NMR data of compounds 51 and 52 in 
CDCl3. 
Position 
δH (ppm) (J in Hz)  δC (ppm)     
51 52 51 52     12 
1 7.65 s 7.60 s 160.1 159.8 
2 - - 135.0 134.2 
3 - - 205.3 206.1 
4 - - 73.1 72.3 
5 6.90 s 6.28 s 
137.1 127.2 
6 - - 148.2 147.4 
7 - 4.83 (1H, d, 9.0) 201.4 81.5 
8 3.35 (1H, d, 5.3) 2.66 (1H, dd, 9.5, 5.5) 54.5 45.2 
9 
- - 73.5 72.8 
10 3.30 (1H, t, 2.6) 3.07 s 58.6 56.9 
11 2.12 s 2.55 m 38.1 37.7 
12a 1.61 (1H, dd, 9.7, 2.9) 2.18 (1H, dd, 14.9, 7.4) 31.5 31.6 
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12b 
2.15 (1H, d, 6.9) 
1.60 (1H, dd, 11.5, 3.7) 
13 - - 62.9 63.3 
14 1.93 (1H, d, 5.4) 1.67 (1H, d, 5.6) 24.3 26.5 
15 - - 26.0 25.7 
16a 4.05* 4.44 (1H, d, 11.8) 
69.1 70.2 
16b 4.18* 4.04 (1H, d, 11.8) 
17 
1.13 (3H, d,1.4) 1.18 s 11.5 56.3 
18 
0.95 (3H, d, 5.8) 0.94 (3H, d, 6.5) 18.5 18.7 
19 
1.82 (3H, d, 1.5) 1.81 (3H, dd, 2.7, 1.4) 10.3 10.2 
20a 
4.25 (1H, dd, 14.6, 1.0) 2.07 s 
63.1 21.0 
20b 
4.36 (1H, dd, 14.6, 1.0) 2.07 s 
1′ 
- - - 170.7 
2′ 
- 2.08 s - 37.7 
1′′ 
- - 179.0 179.0 
2′′ 
2.53 (1H, sep, 7) 2.54 (3H, sep, 7.0) 34.2 34.2 
3′′ 
1.15 (1H, d, 1.0) 1.17 (1H, d, 6.5) 18.5 18.5 
4′′ 
1.15 (1H, d, 1.0) 1.17 (1H, d, 6.5) 18.5 18.5 
1′′′ 
- - 167.9 168.2 
2′′′ 
- - 127.8 127.2 
3′′′ 
6.07 (1H, qd, 7.3, 1.4) 6.08 (1H, qd, 7.3, 1.4) 137.7 138.7 
4′′′ 
1.97 (3H, dd, 7.3, 1.4) 1.96 (3H, dd, 7.3, 1.5) 15.7 15.8 
5′′′ 
1.88 (3H, t, 1.4) 1.87 (3H, t, 1.4) 20.5 20.3 
*undefined 
4.4. Biological activity 
The crude extract of E. cooperi was tested for antimicrobial activities against a Gram-positive 
(Staphylococcus aureus ATCC 12600), two Gram-negative (Pseudomonas aeruginosa ATCC 
10145, Klebsiella pneumoniae ATCC 13883), and a drug-resistant Gram-negative 
(Escherichia coli ATCC 25218) bacteria. The crude extracts showed moderate but promising 
antimicrobial activity. The single compounds were not assayed. 
Table 4.4: Antibacterial activity results. 
 Antibacterial activity (MIC, µg/ml) 
 Gram +ve Gram -ve Drug resistant Gram -ve 
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 S. aureus K. pneumoniae P. aeruginosa E. coli 
E.cooperi 625 625 >5000 >5000 
Neomycin <0.24 0.98 0.98 0.24 
 
4.5 Conclusion 
A phytochemical investigation of E. cooperi led to an isolation of a novel norsesquiterpenoid 
(48), its glycoside derivative, arachiside A (50), glutinol (47), a novel phorbol ester (51) and a 
known phorbol ester (52). 
4.6 Experimental  
4.6.1 General experimental procedure  
Please see Chapter 3 (3.5.1). 
4.6.2 Plant material 
The aerial parts of Euphorbia cooperi N.E.Br. ex A.Berger were collected in May 2017 at the 
University of KwaZulu-Natal Botanical Garden in Pietermaritzburg and was identified by a 
curator, Ms Alison Young. The voucher specimen was deposited to the Bews Herbarium, 
UKZN, School of Life Sciences (Voucher No 2. NU0048866). 
4.6.3 Extraction and isolation of compounds 
The plant material E. cooperi was dried for two weeks indoors at room temperature then 
pulverised to a powder and extracted exhaustively with 1:1 (v/v) of DCM-MeOH for 24 h. This 
was followed by filtration through cotton wool in a glass funnel. The filtrate was then 
concentrated under vacuum using a rotatory evaporator (65 C) to afford a crude (10 g aerial 
crude extract).  
The crude extract was then dissolved and mixed with silica gel and dry-packed on a VLC 
column with silica gel (88 g). The column was eluted with different solvent systems as follows: 
Hex (400 mL), Hex-DCM (9:1, 400 mL), DCM-EtOAc (20:1, 630 mL), EtOAc (400 mL), 
EtOAc-MeOH (5:1, 480 mL), MeOH (600 mL) and distilled H2O (300 mL). The fractions were 
then dried in the fume-hood over night to afford dry fractions then weighed (Table 4.5). 
Table 4.5. Fractions obtained from the VLC fractionation of the crude extract of E. cooperi. 
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Fraction Mass (mg) Book code 
1 990 SSH-2-3A 
2 1330 SSH-2-3B 
3 890 SSH-2-3C 
4 420 SSH-2-3D 
5 360 SSH-2-3E 
6 645 SSH-2-3F 
7 
440 SSH-2-3G 
 
Based on the TLC profiles of the fractions obtained, fractions D, E, F and G were further 
fractionated. Fraction F and G were combined since similar spots on TLC were observed, the 
combined fraction was then subjected to column chromatography (18 x 3 cm) packed with 
silica gel. The column was eluted with a mixture of DCM and MeOH as follows: DCM (400 
mL), DCM-MeOH (9:1, 200 mL), DCM-MeOH (7:3, 200 mL), DCM-MeOH (1:1, 200 mL) 
and MeOH (300 mL). The obtained subfractions (8 mL each) were spotted and combined based 
on the TLC profile to afford 7 subfrations (Table 4.6). Subfractions 4 (SSH-2-6D) was further 
purified by centrifugal thin-layer chromatography on a chromatotron™ (1 mm thickness) using 
DCM-MeOH (9:1) as the solvent system to afford five subfractions (Table 4.7). Subfraction 5 
(SSH-2-7E) was identified to be compound 48 
Table 4.6. Subfractions obtained from fractionation of the combined fractions F and G. 
Fraction Mass (mg) Book code 
1 90 SSH-2-6A 
2 32 SSH-2-6B 
3 24 SSH-2-6C 
4 97 SSH-2-6D 
5 120 SSH-2-6E 
 
Table 4.7. Subfractions obtained by centrifugal thin-layer chromatography of subfraction SSH-
2-6D.  
Fraction Mass (mg) Book code 
1 5 SSH-2-7A 
2 12 SSH-2-7B 
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3 6 SSH-2-7C 
4 12 SSH-2-7D 
5 23 SSH-2-7E 
6 9 SSH-2-7F 
7 
10 SSH-2-7G 
 
Subfration 5 (SSH-2-6E) was fractionated on a chromatotron™ (2 mm thickness) using DCM-
MeOH (7:3) as the solvent system. Three subfrations were obtained (Table 4.8). Fraction 2 
(SS-2-13B) was identified as compound 50.  
Table 4.8. Subfractions obtained from fractionation of subfration SSH-6E. 
Fraction Mass (mg) Book code 
1 50 SSH-2-13A 
2 23 SSH-2-13B 
3 30 SSH-2-13C 
Fractions 3D and 3E were also combined based on the TLC profile. The combined fraction was 
subjected to column chromatography (25 x 4 cm) packed with silica gel. The column was then 
eluted a mixture of Hex and EtOAc as follows: Hex (500 mL), Hex-EtOAc (9:1, 400 mL), 
Hex-EtOAc (8:2, 630 mL), Hex-EtOAc (7:3, 400 mL), Hex-EtOAc (6:4, 480 mL), Hex-EtOAc 
(1:1, 300 mL), Hex-EtOAc (4:6, 200 mL), Hex-EtOAc (1:9, 400 mL), EtOAc (200 mL), then 
eluted with MeOH (100 mL). Subfractions obtained (8 mL each) were combined based on the 
TLC profile. 15 subfractions were obtained (Table 4.9).  
Table 4.9. Subfractions obtained from the fractionation of the combined fractions 3D and 3E. 
Fraction Mass (mg) Book code 
1 90 SSH-2-15A 
2 33 SSH-2-15B 
3 89 SSH-2-15C 
4 60 SSH-2-15D 
5 80 SSH-2-15E 
6 45 SSH-2-15F 
7 
12 SSH-2-15G 
8 
77 SSH-2-15H 
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9 
89 SSH-2-15I 
10 
50 SSH-2-15J 
11 
23 SSH-2-15K 
12 
45 SSH-2-15L 
13 
76 SSH-2-15M 
14 
87 SSH-2-15N 
15 
99 SSH-2-15O 
Subfraction 2 (SSH-2-15B) was identified as compound 47. Subfraction 4 (SSH-2-15D) was 
fractionated on a small column (18 x 2 cm) packed with silica gel and eluted using Hex-EtOAc 
(7:3) as the solvent system to afford 6 subfractions (Table 4.10). Subfration 1 (SSH-2-19A) 
was identified to be compound 51 and subfraction 4 (SSH-2-19D) was identified to compound 
52. 
 
Table 4.10. Subractions obtained from fractionation of subfration SSH-15D. 
Fraction Mass (mg) Book code 
1 21 SSH-2-19A 
2 15 SSH-2-19B 
3 8 SSH-2-19C 
4 16 SSH-2-19D 
5 6 SSH-2-19E 
6 14 SSH-2-19F 
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Figure 4.28. Flow diagram of the isolation of compound 47, 48, 50, 51 and 52. 
4.6.4 Biological assay 
4.6.5 Physical data of isolated compounds 
Glutinol (47) was isolated as a white powder. 1H and 13C NMR data are collected in Table 4.1. 
HR-ESI-(+)-MS m/z 427.3948 (calcd for C30H51O, 427.3940). 
Euphorbilactone (48) was isolated as a white solid. 1H NMR (400 MHz, CDCl3) δH 1.84 (H-
4ax), 156-1.64 (H-4eq), 3.96 (H-5), 2.15 (H-6ax), 1.56-1.64 (H-6aq), 2.36 (H-8), 5.71 (H-9), 5.81 
(H-10), 4.36 (H-11), 1.29 (H-12), 1.35 (H-13), 1.10 (H-14). 13C NMR (400 MHz, CDCl3):δC  
179.2 (C-1), 46.3 (C-3), 36.2 (C-4), 65.2 (C-5), 38.0 (C-6), 85.3 (C-7), 57.7 (C-8), 120.6 (C-
9), 142.2 (C-10), 68.0 (C-11), 23.7 (C-12), 23.4 (C-13), 18.9 (C-14). 
Arachiside A (50) was isolated as a yellow oil. 1H and 13C NMR data are collected in Table 
4.2. HR-ESI-(+)-MS m/z 425.1793 (calcd for C19H30O9Na, 425.1788).
  
16-Angeloyloxy-13-isobutanoyloxy-4β,9,20-trihydroxytiglia-1,5-diene-3,7-dione (51) was 
isolated as a yellow oil. 1H and 13C NMR data are collected in Table 4.3. HR-ESI-(+)-MS m/z 
553.2411 (calcd for C29H39O9Na, 553.2414).
  
20-Acetoxy-16-angeloyloxy-13α-isobutanoyloxy-4β,7β,9α,20-tetrahydroxytiglia-1,5-
diene-3-one (52) was isolate as a yellow oil. 1H and 13C NMR data are collected in Table 4.3. 
HR-ESI-(+)-MS m/z 595.2545 (calcd for C31H40O10Na, 595.2519).  
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CHAPTER 5 
Conclusion and Future Work 
Plants are playing an important role in natural products chemistry, especially in the discovery 
of new drugs that can be used for the treatment of infectious diseases and cancer. The need for 
the discovery of new pharmacologically active compounds is a global priority as new diseases 
and drug resistance are emerging and spreading throughout the world. South Africa has a rich 
biodiversity of plants, many of which are used in traditional medicine. However, the 
phytochemistry and the bioactivity of many of the plants have not been investigated. 
This project aimed at isolating and characterising bioactive compounds from Euphorbiaceae 
plant species indigenous to South Africa. Antidesma venosum E.Mey. ex Tul. and Euphorbia 
cooperi N.E.Br. ex A.Berger were investigated. The crude extracts as well as some single 
compounds were assayed for antimicrobial activities. 
Six known compounds, (-)-loliolide, β-sitosteroln 3-O-D-glucoside, lutein, 4-
hydroxyphenylethyl trans-ferulate, pheophytin A, and pheophytin B, were isolated from A. 
venosum. With the exception of pheophytin A, none of these compounds have previously been 
identified in A. venosum.   
A novel norsesquiterpenoid named euphorbilactone and a known glycosyl derivative, 
arachiside A, a triterpenoid glutinol, a known phorbol ester, 16-angeloyloxy-13α-
isobutanoyloxy-4β,9α,20-trihydroxytiglia-1,5-diene-3,7-dione, and a novel phorbol ester, 20-
acetoxy-16-angeloyloxy-13α-isobutanoyloxy-4β,9α,20-tetrahydroxytiglia-1,5-diene-3-one, 
were isolate from E. cooperi. None of these compounds has previously been identified in E. 
cooperi. With phorbol ester, the structure and configuration of the five- and seven-membered 
ring determine the biological activity of the compounds. The position of the double bond in the 
seven-membered ring of two phorbol ester 51 and 52 is different to all the known phrobol 
derivatives and it would be interesting to see what the effect of this structural feature will be 
on the activity of 51 and 52. 
The crude extracts of the plants showed moderate but promising antimicrobial activity. The 
pure compounds did not show any antimicrobial activity. Due to time limitations, further 
studies on bioactivity were not conducted and this should be addressed in future work. 
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This investigation revealed that South African Euphorbiaceae have the potential of producing 
novel bioactive compounds, thus further investigation of these and related plant species within 
the family would be important in the discovery of new bioactive compounds. 
In future work, the first priority should be to investigate the bioactivity of the isolated 
compounds. A second priority should be to identify readily available Euphorbia species that 
could yield more novel compounds. 
 
In conclusion, twelve compounds have been isolated, two of which are new compounds. Future 
work should include the determination of the biological activity of these compounds. 
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Plate 1. 13C and DEPT-135 NMR spectra of compound 39. 
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Plate 2. COSY NMR spectrum of compound 39. 
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Plate 3. HSQC NMR spectrum of compound 39. 
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Plate 4. HMBC NMR spectrum of compound 39. 
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Plate 5. 13C and DEPT-135 NMR spectra of compound 40. 
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Plate 6. COSY NMR spectrum of compound 40. 
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Plate 7. HSQC NMR spectrum of compound 40. 
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Plate 8. HMBC NMR spectrum of compound 40. 
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Plate 9. COSY NMR spectrum of compound 47 
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Plate 10 COSY NMR spectrum of compound 50 
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Plate 11 HSQC NMR spectrum of compound 50 
 
 
 
